In the last 12 months, insiders at LABCORP HOLDINGS INC. ($LH) filed 664 transactions with the SEC: 0 open-market purchases totaling $0 and 66 sales totaling $47,025,557. Net insider sentiment: net selling.
LABCORP HOLDINGS INC. operates in the Services-medical laboratories industry (Industrial Applications and Services sector).
Most Active Insiders
- Schechter Adam H (President & CEO) — 44 transactions totaling $24,461,521
- EISENBERG GLENN A (Chief Financial Officer, EVP) — 29 transactions totaling $16,989,941
- Schroeder Mark S (EVP, Pres Diagnostics & COO) — 57 transactions totaling $8,883,981
- Schechter Adam H (President and CEO) — 3 transactions totaling $6,886,709
- EISENBERG GLENN A (Executive Vice President) — 16 transactions totaling $6,314,783
View all SEC Filings for LABCORP HOLDINGS INC. (LH).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 26, 2026 | Oyegunwa Akinbolade | EVP, CIO & CTO | A | Common Stock | 1340 | $0.00 | 5,446.2530 | 83,000,000 | 32.63% | 0.00% |
| March 26, 2026 | GRAHAM ANITA Z | EVP, CHRO | F | Common Stock | 2879 | $268.38 | 5,185.0000 | 83,000,000 | 35.70% | 0.00% |
| March 26, 2026 | GRAHAM ANITA Z | EVP, CHRO | A | Common Stock | 6604 | $0.00 | 8,064.0000 | 83,000,000 | 452.33% | 0.01% |
| March 26, 2026 | Schechter Adam H | President & CEO | F | Common Stock | 26106 | $268.38 | 113,137.0000 | 83,000,000 | 18.75% | 0.03% |
| March 26, 2026 | Schechter Adam H | President & CEO | A | Common Stock | 58470 | $0.00 | 139,243.0000 | 83,000,000 | 72.39% | 0.07% |
| March 26, 2026 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | F | Common Stock | 481 | $268.38 | 4,851.0000 | 83,000,000 | 9.02% | 0.00% |
| March 26, 2026 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | A | Common Stock | 1184 | $0.00 | 5,332.0000 | 83,000,000 | 28.54% | 0.00% |
| March 26, 2026 | Kyle Kathryn W | EVP, Chief Legal Officer | F | Common Stock | 451 | $268.38 | 4,575.4574 | 83,000,000 | 8.97% | 0.00% |
| March 26, 2026 | Kyle Kathryn W | EVP, Chief Legal Officer | A | Common Stock | 1584 | $0.00 | 5,026.4574 | 83,000,000 | 46.01% | 0.00% |
| March 27, 2026 | Meltzer Jonathan C | EVP, Operations | S | Common Stock | 839 | $267.05 | 3,620.3256 | 83,000,000 | 18.81% | 0.00% |
| March 26, 2026 | Meltzer Jonathan C | EVP, Operations | F | Common Stock | 711 | $268.38 | 4,459.3256 | 83,000,000 | 13.75% | 0.00% |
| March 26, 2026 | Meltzer Jonathan C | EVP, Operations | A | Common Stock | 2388 | $0.00 | 5,170.3256 | 83,000,000 | 85.83% | 0.00% |
| March 26, 2026 | Summy Amy B. | EVP, Chief Marketing Officer | A | Common Stock | 3994 | $0.00 | 9,715.5000 | 83,000,000 | 69.81% | 0.00% |
| March 26, 2026 | Summy Amy B. | EVP, Chief Marketing Officer | F | Common Stock | 1836 | $268.38 | 7,879.5000 | 83,000,000 | 18.90% | 0.00% |
| March 26, 2026 | Oyegunwa Akinbolade | EVP, CIO & CTO | F | Common Stock | 382 | $268.38 | 5,064.2530 | 83,000,000 | 7.01% | 0.00% |
| March 26, 2026 | Schroeder Mark S | EVP, Pres Diagnostics & COO | A | Common Stock | 9304 | $0.00 | 15,777.1426 | 83,000,000 | 143.73% | 0.01% |
| March 26, 2026 | Schroeder Mark S | EVP, Pres Diagnostics & COO | F | Common Stock | 4600 | $268.38 | 11,177.1426 | 83,000,000 | 29.16% | 0.01% |
| March 26, 2026 | Schroeder Mark S | EVP, Pres Diagnostics & COO | A | Common Stock | 2968 | $0.00 | 14,145.1426 | 83,000,000 | 26.55% | 0.00% |
| March 26, 2026 | Schroeder Mark S | EVP, Pres Diagnostics & COO | F | Common Stock | 1468 | $268.38 | 12,677.1426 | 83,000,000 | 10.38% | 0.00% |
| March 26, 2026 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | A | Common Stock | 9304 | $0.00 | 39,410.9234 | 83,000,000 | 30.90% | 0.01% |
| March 26, 2026 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | F | Common Stock | 4042 | $268.38 | 35,368.9234 | 83,000,000 | 10.26% | 0.00% |
| March 26, 2026 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | A | Common Stock | 1986 | $0.00 | 37,354.9234 | 83,000,000 | 5.62% | 0.00% |
| March 26, 2026 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | F | Common Stock | 863 | $268.38 | 36,491.9234 | 83,000,000 | 2.31% | 0.00% |
| March 26, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | A | Common Stock | 2388 | $0.00 | 4,240.2194 | 83,000,000 | 128.93% | 0.00% |
| March 26, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | F | Common Stock | 755 | $268.38 | 3,485.2194 | 83,000,000 | 17.81% | 0.00% |
| March 27, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | S | Common Stock | 1633 | $267.05 | 1,852.2194 | 83,000,000 | 46.86% | 0.00% |
| March 26, 2026 | Vaughn Bryan T | EVP, Diagnostics | A | Common Stock | 1584 | $0.00 | 7,196.5702 | 83,000,000 | 28.22% | 0.00% |
| March 26, 2026 | Vaughn Bryan T | EVP, Diagnostics | F | Common Stock | 451 | $268.38 | 6,745.5702 | 83,000,000 | 6.27% | 0.00% |
| March 26, 2026 | van der Vaart Sandra D | EVP, Corporate Affairs | A | Common Stock | 6382 | $0.00 | 8,960.9467 | 83,000,000 | 247.47% | 0.01% |
| March 26, 2026 | van der Vaart Sandra D | EVP, Corporate Affairs | F | Common Stock | 2722 | $268.38 | 6,238.9467 | 83,000,000 | 30.38% | 0.00% |
| March 3, 2026 | Schechter Adam H | President & CEO | S | Common Stock | 8705 | $279.96 | 80,773.0000 | 83,000,000 | 9.73% | 0.01% |
| Feb. 27, 2026 | van der Vaart Sandra D | EVP, Corporate Affairs | S | Common Stock | 548 | $284.91 | 2,578.9467 | 83,000,000 | 17.51% | 0.00% |
| Feb. 24, 2026 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | S | Common Stock | 1500 | $286.31 | 30,106.9234 | 83,000,000 | 4.75% | 0.00% |
| Feb. 19, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | S | Common Stock | 666 | $277.94 | 1,852.2194 | 83,000,000 | 26.45% | 0.00% |
| Feb. 11, 2026 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | M | Common Stock | 403 | $0.00 | 4,286.0000 | 83,000,000 | 10.38% | 0.00% |
| Feb. 11, 2026 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | M | Restricted Stock Unit | 740 | $0.00 | 4,170.0000 | 83,000,000 | 15.07% | 0.00% |
| Feb. 11, 2026 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | F | Common Stock | 211 | $289.89 | 31,606.9234 | 83,000,000 | 0.66% | 0.00% |
| Feb. 11, 2026 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | M | Common Stock | 740 | $0.00 | 31,817.9234 | 83,000,000 | 2.38% | 0.00% |
| Feb. 11, 2026 | GRAHAM ANITA Z | EVP, CHRO | M | Restricted Stock Unit | 356 | $0.00 | 2,401.0000 | 83,000,000 | 12.91% | 0.00% |
| Feb. 11, 2026 | GRAHAM ANITA Z | EVP, CHRO | F | Common Stock | 109 | $289.89 | 1,460.0000 | 83,000,000 | 6.95% | 0.00% |
| Feb. 11, 2026 | GRAHAM ANITA Z | EVP, CHRO | M | Common Stock | 356 | $0.00 | 1,569.0000 | 83,000,000 | 29.35% | 0.00% |
| Feb. 11, 2026 | Kyle Kathryn W | EVP, Chief Legal Officer | M | Restricted Stock Unit | 216 | $0.00 | 2,264.0000 | 83,000,000 | 8.71% | 0.00% |
| Feb. 11, 2026 | Kyle Kathryn W | EVP, Chief Legal Officer | F | Common Stock | 62 | $289.89 | 3,442.4574 | 83,000,000 | 1.77% | 0.00% |
| Feb. 11, 2026 | Kyle Kathryn W | EVP, Chief Legal Officer | M | Common Stock | 216 | $0.00 | 3,504.4574 | 83,000,000 | 6.57% | 0.00% |
| Feb. 11, 2026 | Meltzer Jonathan C | EVP, Operations | M | Restricted Stock Unit | 243 | $0.00 | 2,694.0000 | 83,000,000 | 8.27% | 0.00% |
| Feb. 12, 2026 | Meltzer Jonathan C | EVP, Operations | S | Common Stock | 87 | $290.42 | 2,782.3256 | 83,000,000 | 3.03% | 0.00% |
| Feb. 11, 2026 | Meltzer Jonathan C | EVP, Operations | F | Common Stock | 70 | $289.89 | 2,869.3256 | 83,000,000 | 2.38% | 0.00% |
| Feb. 11, 2026 | Meltzer Jonathan C | EVP, Operations | M | Common Stock | 243 | $0.00 | 2,939.3256 | 83,000,000 | 9.01% | 0.00% |
| Feb. 11, 2026 | Oyegunwa Akinbolade | EVP, CIO & CTO | M | Restricted Stock Unit | 230 | $0.00 | 2,190.0000 | 83,000,000 | 9.50% | 0.00% |
| Feb. 11, 2026 | Vaughn Bryan T | EVP, Diagnostics | M | Common Stock | 323 | $0.00 | 5,705.5702 | 83,000,000 | 6.00% | 0.00% |
| Feb. 11, 2026 | Vaughn Bryan T | EVP, Diagnostics | F | Common Stock | 93 | $289.89 | 5,612.5702 | 83,000,000 | 1.63% | 0.00% |
| Feb. 11, 2026 | Vaughn Bryan T | EVP, Diagnostics | M | Restricted Stock Unit | 323 | $0.00 | 4,031.0000 | 83,000,000 | 7.42% | 0.00% |
| Feb. 11, 2026 | van der Vaart Sandra D | EVP, Corporate Affairs | M | Common Stock | 376 | $0.00 | 3,225.4864 | 83,000,000 | 13.20% | 0.00% |
| Feb. 11, 2026 | van der Vaart Sandra D | EVP, Corporate Affairs | F | Common Stock | 99 | $289.89 | 3,126.4864 | 83,000,000 | 3.07% | 0.00% |
| Feb. 11, 2026 | van der Vaart Sandra D | EVP, Corporate Affairs | M | Restricted Stock Unit | 376 | $0.00 | 1,141.0000 | 83,000,000 | 24.79% | 0.00% |
| Feb. 11, 2026 | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Common Stock | 806 | $0.00 | 6,732.1426 | 83,000,000 | 13.60% | 0.00% |
| Feb. 11, 2026 | Schroeder Mark S | EVP, Pres Diagnostics & COO | F | Common Stock | 259 | $289.89 | 6,473.1426 | 83,000,000 | 3.85% | 0.00% |
| Feb. 11, 2026 | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Restricted Stock Unit | 806 | $0.00 | 2,358.0000 | 83,000,000 | 25.47% | 0.00% |
| Feb. 11, 2026 | Schechter Adam H | President & CEO | S | Common Stock | 5273 | $284.38 | 87,343.0000 | 83,000,000 | 5.69% | 0.01% |
| Feb. 11, 2026 | Schechter Adam H | President & CEO | M | Common Stock | 3656 | $0.00 | 90,999.0000 | 83,000,000 | 4.19% | 0.00% |
| Feb. 11, 2026 | Schechter Adam H | President & CEO | F | Common Stock | 1521 | $289.89 | 89,478.0000 | 83,000,000 | 1.67% | 0.00% |
| Feb. 11, 2026 | Schechter Adam H | President & CEO | M | Restricted Stock Unit | 3656 | $0.00 | 22,214.0000 | 83,000,000 | 14.13% | 0.00% |
| Feb. 11, 2026 | Oyegunwa Akinbolade | EVP, CIO & CTO | M | Common Stock | 230 | $0.00 | 4,174.2530 | 83,000,000 | 5.83% | 0.00% |
| Feb. 11, 2026 | Oyegunwa Akinbolade | EVP, CIO & CTO | F | Common Stock | 68 | $289.89 | 4,106.2530 | 83,000,000 | 1.63% | 0.00% |
| Feb. 11, 2026 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | F | Common Stock | 138 | $289.89 | 4,148.0000 | 83,000,000 | 3.22% | 0.00% |
| Feb. 11, 2026 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | M | Restricted Stock Unit | 403 | $0.00 | 2,827.0000 | 83,000,000 | 12.48% | 0.00% |
| Feb. 11, 2026 | Rothman Paul | Director | M | Common Stock | 897 | $0.00 | 2,571.0000 | 83,000,000 | 53.58% | 0.00% |
| Feb. 11, 2026 | Rothman Paul | Director | M | Restricted Stock Unit | 897 | $0.00 | 773.0000 | 83,000,000 | 53.71% | 0.00% |
| Feb. 11, 2026 | Wengel Kathryn E | Director | M | Common Stock | 897 | $0.00 | 4,133.0000 | 83,000,000 | 27.72% | 0.00% |
| Feb. 11, 2026 | Wengel Kathryn E | Director | M | Restricted Stock Unit | 897 | $0.00 | 773.0000 | 83,000,000 | 53.71% | 0.00% |
| Feb. 11, 2026 | Parham Richelle P | Director | M | Common Stock | 897 | $0.00 | 3,366.0000 | 83,000,000 | 36.33% | 0.00% |
| Feb. 11, 2026 | Parham Richelle P | Director | M | Restricted Stock Unit | 897 | $0.00 | 773.0000 | 83,000,000 | 53.71% | 0.00% |
| Feb. 11, 2026 | NEUPERT PETER M | Director | M | Common Stock | 897 | $0.00 | 13,784.0000 | 83,000,000 | 6.96% | 0.00% |
| Feb. 11, 2026 | NEUPERT PETER M | Director | M | Restricted Stock Unit | 897 | $0.00 | 773.0000 | 83,000,000 | 53.71% | 0.00% |
| Feb. 11, 2026 | Kong Garheng | Director | M | Common Stock | 897 | $0.00 | 13,739.0000 | 83,000,000 | 6.98% | 0.00% |
| Feb. 11, 2026 | Kong Garheng | Director | M | Restricted Stock Unit | 897 | $0.00 | 773.0000 | 83,000,000 | 53.71% | 0.00% |
| Feb. 11, 2026 | Kliphouse Kirsten Marie | Director | M | Common Stock | 897 | $0.00 | 3,160.0000 | 83,000,000 | 39.64% | 0.00% |
| Feb. 11, 2026 | Kliphouse Kirsten Marie | Director | M | Restricted Stock Unit | 897 | $0.00 | 773.0000 | 83,000,000 | 53.71% | 0.00% |
| Feb. 11, 2026 | Davis Jeffrey A. | Director | M | Common Stock | 897 | $0.00 | 5,460.0000 | 83,000,000 | 19.66% | 0.00% |
| Feb. 11, 2026 | Davis Jeffrey A. | Director | M | Restricted Stock Unit | 897 | $0.00 | 773.0000 | 83,000,000 | 53.71% | 0.00% |
| Feb. 11, 2026 | ANDERSON KERRII B | Director | M | Common Stock | 897 | $0.00 | 9,851.0000 | 83,000,000 | 10.02% | 0.00% |
| Feb. 11, 2026 | ANDERSON KERRII B | Director | M | Restricted Stock Unit | 897 | $0.00 | 773.0000 | 83,000,000 | 53.71% | 0.00% |
| Feb. 11, 2026 | Summy Amy B. | EVP, Chief Marketing Officer | M | Common Stock | 230 | $0.00 | 5,804.5000 | 83,000,000 | 4.13% | 0.00% |
| Feb. 11, 2026 | Summy Amy B. | EVP, Chief Marketing Officer | F | Common Stock | 83 | $289.89 | 5,721.5000 | 83,000,000 | 1.43% | 0.00% |
| Feb. 11, 2026 | Summy Amy B. | EVP, Chief Marketing Officer | M | Restricted Stock Unit | 230 | $0.00 | 1,304.0000 | 83,000,000 | 14.99% | 0.00% |
| Feb. 11, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | M | Common Stock | 536 | $0.00 | 2,564.2194 | 83,000,000 | 26.43% | 0.00% |
| Feb. 11, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | F | Common Stock | 160 | $289.89 | 2,404.2194 | 83,000,000 | 6.24% | 0.00% |
| Feb. 11, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | M | Common Stock | 160 | $0.00 | 2,564.2194 | 83,000,000 | 6.65% | 0.00% |
| Feb. 11, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | F | Common Stock | 46 | $289.89 | 2,518.2194 | 83,000,000 | 1.79% | 0.00% |
| Feb. 11, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | M | Restricted Stock Unit | 536 | $0.00 | 2,128.0000 | 83,000,000 | 20.12% | 0.00% |
| Feb. 11, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | M | Restricted Stock Unit | 160 | $0.00 | 1,968.0000 | 83,000,000 | 7.52% | 0.00% |
| Feb. 11, 2026 | Wang Julia Aijun | Chief Financial Officer, EVP | M | Common Stock | 860 | $0.00 | 2,062.2390 | 83,000,000 | 71.53% | 0.00% |
| Feb. 11, 2026 | Wang Julia Aijun | Chief Financial Officer, EVP | F | Common Stock | 245 | $289.89 | 1,817.2390 | 83,000,000 | 11.88% | 0.00% |
| Feb. 11, 2026 | Wang Julia Aijun | Chief Financial Officer, EVP | M | Restricted Stock Unit | 860 | $0.00 | 4,964.0000 | 83,000,000 | 14.77% | 0.00% |
| Feb. 10, 2026 | Kong Garheng | Director | A | Restricted Stock Unit | 773 | $0.00 | 1,670.0000 | 83,000,000 | 86.18% | 0.00% |
| Feb. 10, 2026 | Rothman Paul | Director | A | Restricted Stock Unit | 733 | $0.00 | 1,670.0000 | 83,000,000 | 78.23% | 0.00% |
| Feb. 10, 2026 | Sampson John H | Director | A | Restricted Stock Unit | 773 | $0.00 | 773.0000 | 83,000,000 | 9999.99% | 0.00% |
| Feb. 10, 2026 | Wengel Kathryn E | Director | A | Restricted Stock Unit | 773 | $0.00 | 1,670.0000 | 83,000,000 | 86.18% | 0.00% |
| Feb. 10, 2026 | Parham Richelle P | Director | A | Restricted Stock Unit | 773 | $0.00 | 1,670.0000 | 83,000,000 | 86.18% | 0.00% |
| Feb. 10, 2026 | NEUPERT PETER M | Director | A | Restricted Stock Unit | 773 | $0.00 | 1,670.0000 | 83,000,000 | 86.18% | 0.00% |
| Feb. 10, 2026 | Kliphouse Kirsten Marie | Director | A | Restricted Stock Unit | 773 | $0.00 | 1,670.0000 | 83,000,000 | 86.18% | 0.00% |
| Feb. 10, 2026 | Davis Jeffrey A. | Director | A | Restricted Stock Unit | 773 | $0.00 | 1,670.0000 | 83,000,000 | 86.18% | 0.00% |
| Feb. 10, 2026 | Bulto Carulla Victor | Director | A | Restricted Stock Unit | 773 | $0.00 | 909.0000 | 83,000,000 | 568.38% | 0.00% |
| Feb. 10, 2026 | ANDERSON KERRII B | Director | A | Restricted Stock Unit | 773 | $0.00 | 1,670.0000 | 83,000,000 | 86.18% | 0.00% |
| Feb. 10, 2026 | Meltzer Jonathan C | EVP, Operations | S | Common Stock | 91 | $276.79 | 2,696.3256 | 83,000,000 | 3.26% | 0.00% |
| Feb. 10, 2026 | Meltzer Jonathan C | EVP, Operations | A | Non-qualified Stock Options | 1900 | $0.00 | 1,900.0000 | 83,000,000 | 9999.99% | 0.00% |
| Feb. 10, 2026 | Meltzer Jonathan C | EVP, Operations | A | Restricted Stock Unit | 620 | $0.00 | 2,937.0000 | 83,000,000 | 26.76% | 0.00% |
| Feb. 10, 2026 | Kyle Kathryn W | EVP, Chief Legal Officer | A | Non-qualified Stock Options | 2700 | $0.00 | 2,700.0000 | 83,000,000 | 9999.99% | 0.00% |
| Feb. 10, 2026 | Kyle Kathryn W | EVP, Chief Legal Officer | A | Restricted Stock Unit | 880 | $0.00 | 2,480.0000 | 83,000,000 | 55.00% | 0.00% |
| Feb. 10, 2026 | Vaughn Bryan T | EVP, Diagnostics | A | Non-qualified Stock Options | 2200 | $0.00 | 2,200.0000 | 83,000,000 | 9999.99% | 0.00% |
| Feb. 10, 2026 | Vaughn Bryan T | EVP, Diagnostics | A | Restricted Stock Unit | 730 | $0.00 | 4,354.0000 | 83,000,000 | 20.14% | 0.00% |
| Feb. 10, 2026 | Wang Julia Aijun | Chief Financial Officer, EVP | A | Non-qualified Stock Options | 7100 | $0.00 | 7,100.0000 | 83,000,000 | 9999.99% | 0.01% |
| Feb. 10, 2026 | Wang Julia Aijun | Chief Financial Officer, EVP | A | Restricted Stock Unit | 2350 | $0.00 | 5,824.0000 | 83,000,000 | 67.65% | 0.00% |
| Feb. 10, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | A | Non-qualified Stock Options | 1300 | $0.00 | 1,300.0000 | 83,000,000 | 9999.99% | 0.00% |
| Feb. 10, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | A | Restricted Stock Unit | 440 | $0.00 | 2,664.0000 | 83,000,000 | 19.78% | 0.00% |
| Feb. 10, 2026 | Oyegunwa Akinbolade | EVP, CIO & CTO | A | Non-qualified Stock Options | 2400 | $0.00 | 2,400.0000 | 83,000,000 | 9999.99% | 0.00% |
| Feb. 10, 2026 | Oyegunwa Akinbolade | EVP, CIO & CTO | A | Restricted Stock Unit | 810 | $0.00 | 2,420.0000 | 83,000,000 | 50.31% | 0.00% |
| Feb. 10, 2026 | Summy Amy B. | EVP, Chief Marketing Officer | A | Non-qualified Stock Options | 1900 | $0.00 | 1,900.0000 | 83,000,000 | 9999.99% | 0.00% |
| Feb. 10, 2026 | Summy Amy B. | EVP, Chief Marketing Officer | A | Restricted Stock Unit | 620 | $0.00 | 1,534.0000 | 83,000,000 | 67.83% | 0.00% |
| Feb. 10, 2026 | GRAHAM ANITA Z | EVP, CHRO | A | Non-qualified Stock Options | 4100 | $0.00 | 4,100.0000 | 83,000,000 | 9999.99% | 0.00% |
| Feb. 10, 2026 | GRAHAM ANITA Z | EVP, CHRO | A | Restricted Stock Unit | 1360 | $0.00 | 2,757.0000 | 83,000,000 | 97.35% | 0.00% |
| Feb. 10, 2026 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | A | Non-qualified Stock Options | 3300 | $0.00 | 3,300.0000 | 83,000,000 | 9999.99% | 0.00% |
| Feb. 10, 2026 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | A | Restricted Stock Unit | 1100 | $0.00 | 3,230.0000 | 83,000,000 | 51.64% | 0.00% |
| Feb. 10, 2026 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | A | Non-qualified Stock Options | 6100 | $0.00 | 6,100.0000 | 83,000,000 | 9999.99% | 0.01% |
| Feb. 10, 2026 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | A | Restricted Stock Unit | 2020 | $0.00 | 4,910.0000 | 83,000,000 | 69.90% | 0.00% |
| Feb. 10, 2026 | Schechter Adam H | President & CEO | A | Non-qualified Stock Options | 31700 | $0.00 | 31,700.0000 | 83,000,000 | 9999.99% | 0.04% |
| Feb. 10, 2026 | Schechter Adam H | President & CEO | A | Restricted Stock Unit | 10440 | $0.00 | 25,870.0000 | 83,000,000 | 67.66% | 0.01% |
| Feb. 6, 2026 | Vaughn Bryan T | EVP, Diagnostics | M | Restricted Stock Unit | 180 | $0.00 | 3,802.0000 | 83,000,000 | 4.52% | 0.00% |
| Feb. 7, 2026 | Vaughn Bryan T | EVP, Diagnostics | M | Common Stock | 178 | $0.00 | 5,443.5702 | 83,000,000 | 3.38% | 0.00% |
| Feb. 6, 2026 | Vaughn Bryan T | EVP, Diagnostics | F | Common Stock | 61 | $277.20 | 5,265.5702 | 83,000,000 | 1.15% | 0.00% |
| Feb. 6, 2026 | Vaughn Bryan T | EVP, Diagnostics | M | Common Stock | 180 | $0.00 | 5,326.5702 | 83,000,000 | 3.50% | 0.00% |
| Feb. 7, 2026 | van der Vaart Sandra D | EVP, Corporate Affairs | M | Restricted Stock Unit | 353 | $0.00 | 1,517.0000 | 83,000,000 | 18.88% | 0.00% |
| Feb. 6, 2026 | van der Vaart Sandra D | EVP, Corporate Affairs | M | Restricted Stock Unit | 387 | $0.00 | 1,870.0000 | 83,000,000 | 17.15% | 0.00% |
| Feb. 9, 2026 | van der Vaart Sandra D | EVP, Corporate Affairs | F | Common Stock | 93 | $274.01 | 2,849.4864 | 83,000,000 | 3.16% | 0.00% |
| Feb. 7, 2026 | van der Vaart Sandra D | EVP, Corporate Affairs | M | Common Stock | 353 | $0.00 | 2,942.4864 | 83,000,000 | 13.63% | 0.00% |
| Feb. 6, 2026 | van der Vaart Sandra D | EVP, Corporate Affairs | F | Common Stock | 101 | $277.20 | 2,589.4864 | 83,000,000 | 3.75% | 0.00% |
| Feb. 6, 2026 | van der Vaart Sandra D | EVP, Corporate Affairs | M | Common Stock | 387 | $0.00 | 2,690.4864 | 83,000,000 | 16.80% | 0.00% |
| Feb. 7, 2026 | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Restricted Stock Unit | 164 | $0.00 | 3,164.0000 | 83,000,000 | 4.93% | 0.00% |
| Feb. 7, 2026 | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Restricted Stock Unit | 517 | $0.00 | 3,328.0000 | 83,000,000 | 13.45% | 0.00% |
| Feb. 6, 2026 | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Restricted Stock Unit | 743 | $0.00 | 3,845.0000 | 83,000,000 | 16.19% | 0.00% |
| Feb. 9, 2026 | Schroeder Mark S | EVP, Pres Diagnostics & COO | F | Common Stock | 53 | $274.01 | 5,926.1426 | 83,000,000 | 0.89% | 0.00% |
| Feb. 9, 2026 | Schroeder Mark S | EVP, Pres Diagnostics & COO | F | Common Stock | 166 | $274.01 | 5,979.1426 | 83,000,000 | 2.70% | 0.00% |
| Feb. 7, 2026 | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Common Stock | 164 | $0.00 | 6,145.1426 | 83,000,000 | 2.74% | 0.00% |
| Feb. 7, 2026 | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Common Stock | 517 | $0.00 | 5,981.1426 | 83,000,000 | 9.46% | 0.00% |
| Feb. 6, 2026 | Schroeder Mark S | EVP, Pres Diagnostics & COO | F | Common Stock | 239 | $277.20 | 5,464.1426 | 83,000,000 | 4.19% | 0.00% |
| Feb. 6, 2026 | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Common Stock | 743 | $0.00 | 5,703.1426 | 83,000,000 | 14.98% | 0.00% |
| Feb. 7, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | M | Restricted Stock Unit | 134 | $0.00 | 2,224.0000 | 83,000,000 | 5.68% | 0.00% |
| Feb. 6, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | M | Restricted Stock Unit | 133 | $0.00 | 2,358.0000 | 83,000,000 | 5.34% | 0.00% |
| Feb. 9, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | F | Common Stock | 46 | $274.01 | 2,028.2194 | 83,000,000 | 2.22% | 0.00% |
| Feb. 7, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | M | Common Stock | 134 | $0.00 | 2,074.2194 | 83,000,000 | 6.91% | 0.00% |
| Feb. 6, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | F | Common Stock | 45 | $277.20 | 1,940.2194 | 83,000,000 | 2.27% | 0.00% |
| Feb. 6, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | M | Common Stock | 133 | $0.00 | 1,985.2194 | 83,000,000 | 7.18% | 0.00% |
| Feb. 7, 2026 | Schechter Adam H | President & CEO | M | Restricted Stock Unit | 3249 | $0.00 | 15,430.0000 | 83,000,000 | 17.39% | 0.00% |
| Feb. 6, 2026 | Schechter Adam H | President & CEO | M | Restricted Stock Unit | 4460 | $0.00 | 18,679.0000 | 83,000,000 | 19.27% | 0.01% |
| Feb. 9, 2026 | Schechter Adam H | President & CEO | F | Common Stock | 1352 | $274.01 | 92,616.0000 | 83,000,000 | 1.44% | 0.00% |
| Feb. 7, 2026 | Schechter Adam H | President & CEO | M | Common Stock | 3249 | $0.00 | 93,968.0000 | 83,000,000 | 3.58% | 0.00% |
| Feb. 6, 2026 | Schechter Adam H | President & CEO | F | Common Stock | 1315 | $277.20 | 90,719.0000 | 83,000,000 | 1.43% | 0.00% |
| Feb. 6, 2026 | Schechter Adam H | President & CEO | M | Common Stock | 4460 | $0.00 | 92,034.0000 | 83,000,000 | 5.09% | 0.01% |
| Feb. 7, 2026 | Oyegunwa Akinbolade | EVP, CIO & CTO | M | Restricted Stock Unit | 149 | $0.00 | 1,610.0000 | 83,000,000 | 8.47% | 0.00% |
| Feb. 6, 2026 | Oyegunwa Akinbolade | EVP, CIO & CTO | M | Restricted Stock Unit | 180 | $0.00 | 1,759.0000 | 83,000,000 | 9.28% | 0.00% |
| Feb. 9, 2026 | Oyegunwa Akinbolade | EVP, CIO & CTO | F | Common Stock | 51 | $274.01 | 3,944.2530 | 83,000,000 | 1.28% | 0.00% |
| Feb. 7, 2026 | Oyegunwa Akinbolade | EVP, CIO & CTO | M | Common Stock | 149 | $0.00 | 3,995.2530 | 83,000,000 | 3.87% | 0.00% |
| Feb. 6, 2026 | Oyegunwa Akinbolade | EVP, CIO & CTO | F | Common Stock | 61 | $277.20 | 3,846.2530 | 83,000,000 | 1.56% | 0.00% |
| Feb. 6, 2026 | Oyegunwa Akinbolade | EVP, CIO & CTO | M | Common Stock | 180 | $0.00 | 3,907.2530 | 83,000,000 | 4.83% | 0.00% |
| Feb. 7, 2026 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | M | Restricted Stock Unit | 111 | $0.00 | 2,890.0000 | 83,000,000 | 3.70% | 0.00% |
| Feb. 7, 2026 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | M | Restricted Stock Unit | 517 | $0.00 | 3,001.0000 | 83,000,000 | 14.70% | 0.00% |
| Feb. 6, 2026 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | M | Restricted Stock Unit | 670 | $0.00 | 3,518.0000 | 83,000,000 | 16.00% | 0.00% |
| Feb. 9, 2026 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | F | Common Stock | 32 | $274.01 | 31,077.9234 | 83,000,000 | 0.10% | 0.00% |
| Feb. 9, 2026 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | F | Common Stock | 148 | $274.01 | 31,109.9234 | 83,000,000 | 0.47% | 0.00% |
| Feb. 7, 2026 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | M | Common Stock | 111 | $0.00 | 31,257.9234 | 83,000,000 | 0.36% | 0.00% |
| Feb. 7, 2026 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | M | Common Stock | 517 | $0.00 | 31,146.9234 | 83,000,000 | 1.69% | 0.00% |
| Feb. 6, 2026 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | F | Common Stock | 209 | $277.20 | 30,629.9234 | 83,000,000 | 0.68% | 0.00% |
| Feb. 6, 2026 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | M | Common Stock | 670 | $0.00 | 30,838.9234 | 83,000,000 | 2.22% | 0.00% |
| Feb. 6, 2026 | Wang Julia Aijun | Chief Financial Officer, EVP | M | Restricted Stock Unit | 893 | $0.00 | 3,474.0000 | 83,000,000 | 20.45% | 0.00% |
| Feb. 6, 2026 | Wang Julia Aijun | Chief Financial Officer, EVP | F | Common Stock | 254 | $277.20 | 1,202.2390 | 83,000,000 | 17.44% | 0.00% |
| Feb. 6, 2026 | Wang Julia Aijun | Chief Financial Officer, EVP | M | Common Stock | 893 | $0.00 | 1,456.2390 | 83,000,000 | 158.55% | 0.00% |
| Feb. 7, 2026 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | M | Restricted Stock Unit | 67 | $0.00 | 2,130.0000 | 83,000,000 | 3.05% | 0.00% |
| Feb. 7, 2026 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | M | Restricted Stock Unit | 222 | $0.00 | 2,197.0000 | 83,000,000 | 9.18% | 0.00% |
| Feb. 6, 2026 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | M | Restricted Stock Unit | 180 | $0.00 | 2,419.0000 | 83,000,000 | 6.93% | 0.00% |
| Feb. 9, 2026 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | F | Common Stock | 23 | $274.01 | 3,883.0000 | 83,000,000 | 0.59% | 0.00% |
| Feb. 9, 2026 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | F | Common Stock | 85 | $274.01 | 3,906.0000 | 83,000,000 | 2.13% | 0.00% |
| Feb. 7, 2026 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | M | Common Stock | 67 | $0.00 | 3,991.0000 | 83,000,000 | 1.71% | 0.00% |
| Feb. 7, 2026 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | M | Common Stock | 222 | $0.00 | 3,924.0000 | 83,000,000 | 6.00% | 0.00% |
| Feb. 6, 2026 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | F | Common Stock | 72 | $277.20 | 3,702.0000 | 83,000,000 | 1.91% | 0.00% |
| Feb. 6, 2026 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | M | Common Stock | 180 | $0.00 | 3,774.0000 | 83,000,000 | 5.01% | 0.00% |
| Feb. 7, 2026 | Summy Amy B. | EVP, Chief Marketing Officer | M | Restricted Stock Unit | 222 | $0.00 | 914.0000 | 83,000,000 | 19.54% | 0.00% |
| Feb. 6, 2026 | Summy Amy B. | EVP, Chief Marketing Officer | M | Restricted Stock Unit | 223 | $0.00 | 1,136.0000 | 83,000,000 | 16.41% | 0.00% |
| Feb. 9, 2026 | Summy Amy B. | EVP, Chief Marketing Officer | F | Common Stock | 80 | $274.01 | 5,574.5000 | 83,000,000 | 1.41% | 0.00% |
| Feb. 7, 2026 | Summy Amy B. | EVP, Chief Marketing Officer | M | Common Stock | 222 | $0.00 | 5,654.5000 | 83,000,000 | 4.09% | 0.00% |
| Feb. 6, 2026 | Summy Amy B. | EVP, Chief Marketing Officer | F | Common Stock | 92 | $277.20 | 5,432.5000 | 83,000,000 | 1.67% | 0.00% |
| Feb. 6, 2026 | Summy Amy B. | EVP, Chief Marketing Officer | M | Common Stock | 223 | $0.00 | 5,524.5000 | 83,000,000 | 4.21% | 0.00% |
| Feb. 7, 2026 | GRAHAM ANITA Z | EVP, CHRO | M | Restricted Stock Unit | 367 | $0.00 | 1,397.0000 | 83,000,000 | 20.80% | 0.00% |
| Feb. 6, 2026 | GRAHAM ANITA Z | EVP, CHRO | M | Restricted Stock Unit | 327 | $0.00 | 1,764.0000 | 83,000,000 | 15.64% | 0.00% |
| Feb. 9, 2026 | GRAHAM ANITA Z | EVP, CHRO | F | Common Stock | 112 | $274.01 | 1,213.0000 | 83,000,000 | 8.45% | 0.00% |
| Feb. 7, 2026 | GRAHAM ANITA Z | EVP, CHRO | M | Common Stock | 367 | $0.00 | 1,325.0000 | 83,000,000 | 38.31% | 0.00% |
| Feb. 6, 2026 | GRAHAM ANITA Z | EVP, CHRO | F | Common Stock | 119 | $277.20 | 958.0000 | 83,000,000 | 11.05% | 0.00% |
| Feb. 6, 2026 | GRAHAM ANITA Z | EVP, CHRO | M | Common Stock | 327 | $0.00 | 1,077.0000 | 83,000,000 | 43.60% | 0.00% |
| Feb. 7, 2026 | Kyle Kathryn W | EVP, Chief Legal Officer | M | Restricted Stock Unit | 178 | $0.00 | 1,600.0000 | 83,000,000 | 10.01% | 0.00% |
| Feb. 6, 2026 | Kyle Kathryn W | EVP, Chief Legal Officer | M | Restricted Stock Unit | 180 | $0.00 | 1,778.0000 | 83,000,000 | 9.19% | 0.00% |
| Feb. 9, 2026 | Kyle Kathryn W | EVP, Chief Legal Officer | F | Common Stock | 61 | $274.01 | 3,288.4574 | 83,000,000 | 1.82% | 0.00% |
| Feb. 7, 2026 | Kyle Kathryn W | EVP, Chief Legal Officer | M | Common Stock | 178 | $0.00 | 3,349.4574 | 83,000,000 | 5.61% | 0.00% |
| Feb. 6, 2026 | Kyle Kathryn W | EVP, Chief Legal Officer | F | Common Stock | 61 | $277.20 | 3,171.4574 | 83,000,000 | 1.89% | 0.00% |
| Feb. 6, 2026 | Kyle Kathryn W | EVP, Chief Legal Officer | M | Common Stock | 180 | $0.00 | 3,232.4574 | 83,000,000 | 5.90% | 0.00% |
| Feb. 7, 2026 | Meltzer Jonathan C | EVP, Operations | M | Restricted Stock Unit | 263 | $0.00 | 2,317.0000 | 83,000,000 | 10.19% | 0.00% |
| Feb. 6, 2026 | Meltzer Jonathan C | EVP, Operations | M | Restricted Stock Unit | 267 | $0.00 | 2,580.0000 | 83,000,000 | 9.38% | 0.00% |
| Feb. 9, 2026 | Meltzer Jonathan C | EVP, Operations | F | Common Stock | 82 | $274.01 | 2,787.3256 | 83,000,000 | 2.86% | 0.00% |
| Feb. 9, 2026 | Meltzer Jonathan C | EVP, Operations | S | Common Stock | 88 | $275.53 | 2,869.3256 | 83,000,000 | 2.98% | 0.00% |
| Feb. 7, 2026 | Meltzer Jonathan C | EVP, Operations | M | Common Stock | 263 | $0.00 | 2,957.3256 | 83,000,000 | 9.76% | 0.00% |
| Feb. 6, 2026 | Meltzer Jonathan C | EVP, Operations | F | Common Stock | 91 | $277.20 | 2,694.3256 | 83,000,000 | 3.27% | 0.00% |
| Feb. 6, 2026 | Meltzer Jonathan C | EVP, Operations | M | Common Stock | 267 | $0.00 | 2,785.3256 | 83,000,000 | 10.60% | 0.00% |
| Feb. 7, 2026 | Vaughn Bryan T | EVP, Diagnostics | M | Restricted Stock Unit | 178 | $0.00 | 3,624.0000 | 83,000,000 | 4.68% | 0.00% |
| Feb. 9, 2026 | Vaughn Bryan T | EVP, Diagnostics | F | Common Stock | 61 | $274.01 | 5,382.5702 | 83,000,000 | 1.12% | 0.00% |
| Dec. 1, 2025 | Bulto Carulla Victor | Director | A | Restricted Stock Unit | 136 | $0.00 | 136.0000 | 83,000,000 | 9999.99% | 0.00% |
| Nov. 11, 2025 | Schechter Adam H | President & CEO | S | Common Stock | 5745 | $262.75 | 87,574.0000 | 83,000,000 | 6.16% | 0.01% |
| Oct. 31, 2025 | Parham Richelle P | Director | S | Common Stock | 7009 | $254.28 | 2,469.0000 | 83,000,000 | 73.95% | 0.01% |
| Nov. 3, 2025 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | F | Common Stock | 179 | $257.84 | 3,594.0000 | 83,000,000 | 4.74% | 0.00% |
| Nov. 1, 2025 | Oyegunwa Akinbolade | EVP, CIO & CTO | M | Restricted Stock Unit | 370 | $0.00 | 1,939.0000 | 83,000,000 | 16.02% | 0.00% |
| Nov. 3, 2025 | Oyegunwa Akinbolade | EVP, CIO & CTO | F | Common Stock | 107 | $257.84 | 3,727.2530 | 83,000,000 | 2.79% | 0.00% |
| Nov. 1, 2025 | Oyegunwa Akinbolade | EVP, CIO & CTO | M | Common Stock | 370 | $0.00 | 3,834.2530 | 83,000,000 | 10.68% | 0.00% |
| Nov. 1, 2025 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | M | Restricted Stock Unit | 370 | $0.00 | 2,599.0000 | 83,000,000 | 12.46% | 0.00% |
| Nov. 1, 2025 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | M | Common Stock | 370 | $0.00 | 3,773.0000 | 83,000,000 | 10.87% | 0.00% |
| Aug. 13, 2025 | van der Vaart Sandra D | EVP, Chief Legal Officer | M | Non-qualified Stock Options | 3903 | $0.00 | 0.0000 | 83,400,000 | 100.00% | 0.00% |
| Aug. 13, 2025 | van der Vaart Sandra D | EVP, Chief Legal Officer | M | Common Stock | 3903 | $131.43 | 6,176.6691 | 83,400,000 | 171.66% | 0.00% |
| Aug. 13, 2025 | van der Vaart Sandra D | EVP, Chief Legal Officer | S | Common Stock | 3903 | $271.42 | 2,273.6691 | 83,400,000 | 63.19% | 0.00% |
| Aug. 11, 2025 | Schechter Adam H | President & CEO | S | Common Stock | 5643 | $266.78 | 93,319.0000 | 83,400,000 | 5.70% | 0.01% |
| July 30, 2025 | Gilliland Dwight Gary | Director | S | Common Stock | 2000 | $264.95 | 6,656.0000 | 83,400,000 | 23.11% | 0.00% |
| July 29, 2025 | Wilkinson Peter J | SVP, Chief Accounting Officer | S | Common Stock | 102 | $261.01 | 1,952.2194 | 83,400,000 | 4.97% | 0.00% |
| July 29, 2025 | Wilkinson Peter J | SVP, Chief Accounting Officer | S | Common Stock | 100 | $261.04 | 1,852.2194 | 83,400,000 | 5.12% | 0.00% |
| July 24, 2025 | ANDERSON KERRII B | Director | S | Common Stock | 3500 | $280.00 | 8,666.0000 | 83,400,000 | 28.77% | 0.00% |
| July 24, 2025 | ANDERSON KERRII B | Director | S | Common Stock | 3500 | $280.00 | 8,666.0000 | 83,400,000 | 28.77% | 0.00% |
| July 1, 2025 | ANDERSON KERRII B | Director | S | Common Stock | 500 | $265.00 | 12,454.0000 | 83,400,000 | 3.86% | 0.00% |
| June 11, 2025 | ANDERSON KERRII B | Director | S | Common Stock | 500 | $260.00 | 12,954.0000 | 83,400,000 | 3.72% | 0.00% |
| June 3, 2025 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | S | Common Stock | 2000 | $247.00 | 30,066.6573 | 83,400,000 | 6.24% | 0.00% |
| May 12, 2025 | Schechter Adam H | President & CEO | S | Common Stock | 6105 | $248.73 | 98,962.0000 | 83,400,000 | 5.81% | 0.01% |
| May 1, 2025 | van der Vaart Sandra D | EVP, Chief Legal Officer | S | Common Stock | 1900 | $238.36 | 2,243.5397 | 83,400,000 | 45.85% | 0.00% |
| May 1, 2025 | Wilkinson Peter J | SVP, Chief Accounting Officer | S | Common Stock | 829 | $242.27 | 2,054.2194 | 83,400,000 | 28.75% | 0.00% |
| April 1, 2025 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | M | Common Stock | 4083 | $0.00 | 4,813.0000 | 83,400,000 | 559.32% | 0.00% |
| April 1, 2025 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | M | Restricted Stock Unit | 204 | $0.00 | 2,969.0000 | 83,400,000 | 6.43% | 0.00% |
| April 1, 2025 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | M | Restricted Stock Unit | 4083 | $0.00 | 3,173.0000 | 83,400,000 | 56.27% | 0.00% |
| April 1, 2025 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | F | Common Stock | 68 | $232.65 | 3,403.0000 | 83,400,000 | 1.96% | 0.00% |
| April 1, 2025 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | M | Common Stock | 204 | $0.00 | 3,471.0000 | 83,400,000 | 6.24% | 0.00% |
| April 1, 2025 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | F | Common Stock | 1546 | $232.65 | 3,267.0000 | 83,400,000 | 32.12% | 0.00% |
| March 28, 2025 | Summy Amy B. | EVP, Chief Marketing Officer | S | Common Stock | 758 | $231.67 | 5,301.5000 | 83,400,000 | 12.51% | 0.00% |
| March 27, 2025 | EISENBERG GLENN A | Executive Vice President | F | Common Stock | 3630 | $231.67 | 37,920.0000 | 83,400,000 | 8.74% | 0.00% |
| March 27, 2025 | EISENBERG GLENN A | Executive Vice President | A | Common Stock | 8305 | $0.00 | 41,550.0000 | 83,400,000 | 24.98% | 0.01% |
| March 27, 2025 | Schechter Adam H | President & CEO | F | Common Stock | 13584 | $231.67 | 105,067.0000 | 83,400,000 | 11.45% | 0.02% |
| March 27, 2025 | Schechter Adam H | President & CEO | A | Common Stock | 30469 | $0.00 | 118,651.0000 | 83,400,000 | 34.55% | 0.04% |
| March 27, 2025 | van der Vaart Sandra D | EVP, Chief Legal Officer | F | Common Stock | 1352 | $231.67 | 4,143.5397 | 83,400,000 | 24.60% | 0.00% |
| March 27, 2025 | van der Vaart Sandra D | EVP, Chief Legal Officer | A | Common Stock | 3325 | $0.00 | 5,495.5397 | 83,400,000 | 153.19% | 0.00% |
| March 28, 2025 | Schroeder Mark S | EVP, Pres Diagnostics & COO | S | Common Stock | 2635 | $231.67 | 4,960.1426 | 83,400,000 | 34.69% | 0.00% |
| March 27, 2025 | Schroeder Mark S | EVP, Pres Diagnostics & COO | F | Common Stock | 2205 | $231.67 | 7,595.1426 | 83,400,000 | 22.50% | 0.00% |
| March 27, 2025 | Schroeder Mark S | EVP, Pres Diagnostics & COO | A | Common Stock | 4840 | $0.00 | 9,800.1426 | 83,400,000 | 97.58% | 0.01% |
| March 27, 2025 | Summy Amy B. | EVP, Chief Marketing Officer | F | Common Stock | 562 | $231.67 | 6,059.5000 | 83,400,000 | 8.49% | 0.00% |
| March 27, 2025 | Oyegunwa Akinbolade | EVP, CIO & CTO | F | Common Stock | 198 | $231.67 | 3,464.2530 | 83,400,000 | 5.41% | 0.00% |
| March 27, 2025 | Oyegunwa Akinbolade | EVP, CIO & CTO | A | Common Stock | 688 | $0.00 | 3,662.2530 | 83,400,000 | 23.13% | 0.00% |
| March 27, 2025 | Wilkinson Peter J | SVP, Chief Accounting Officer | F | Common Stock | 359 | $231.67 | 2,883.2194 | 83,400,000 | 11.07% | 0.00% |
| March 27, 2025 | Wilkinson Peter J | SVP, Chief Accounting Officer | A | Common Stock | 1249 | $0.00 | 3,242.2194 | 83,400,000 | 62.66% | 0.00% |
| March 27, 2025 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | F | Common Stock | 2109 | $231.67 | 32,066.6573 | 83,400,000 | 6.17% | 0.00% |
| March 27, 2025 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | A | Common Stock | 4840 | $0.00 | 34,175.6573 | 83,400,000 | 16.50% | 0.01% |
| March 27, 2025 | BERBERIAN LANCE | EVP, Special Advisor, Strategy | F | Common Stock | 1353 | $231.67 | 18,652.0000 | 83,400,000 | 6.76% | 0.00% |
| March 27, 2025 | BERBERIAN LANCE | EVP, Special Advisor, Strategy | A | Common Stock | 3325 | $0.00 | 20,005.0000 | 83,400,000 | 19.93% | 0.00% |
| March 27, 2025 | Summy Amy B. | EVP, Chief Marketing Officer | A | Common Stock | 2077 | $0.00 | 6,621.5000 | 83,400,000 | 45.70% | 0.00% |
| March 5, 2025 | ANDERSON KERRII B | Director | S | Common Stock | 500 | $255.63 | 13,454.0000 | 83,400,000 | 3.58% | 0.00% |
| Feb. 28, 2025 | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Non-qualified Stock Options | 3903 | $0.00 | 0.0000 | 83,400,000 | 100.00% | 0.00% |
| Feb. 28, 2025 | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Common Stock | 3903 | $131.43 | 10,299.1426 | 83,400,000 | 61.02% | 0.00% |
| Feb. 28, 2025 | Schroeder Mark S | EVP, Pres Diagnostics & COO | S | Common Stock | 5339 | $249.23 | 4,960.1426 | 83,400,000 | 51.84% | 0.01% |
| Feb. 25, 2025 | van der Vaart Sandra D | EVP, Chief Legal Officer | S | Common Stock | 1314 | $251.30 | 2,170.5397 | 83,400,000 | 37.71% | 0.00% |
| Feb. 24, 2025 | Summy Amy B. | EVP, Chief Marketing Officer | S | Common Stock | 226 | $250.40 | 4,544.5000 | 83,400,000 | 4.74% | 0.00% |
| Feb. 18, 2025 | Wilkinson Peter J | SVP, Chief Accounting Officer | M | Non-qualified Stock Options | 1413 | $0.00 | 0.0000 | 83,400,000 | 100.00% | 0.00% |
| Aug. 1, 2022 | Wilkinson Peter J | SVP, Chief Accounting Officer | G | Common Stock | 351 | $0.00 | 1,993.2194 | 93,100,000 | 14.97% | 0.00% |
| Feb. 18, 2025 | Wilkinson Peter J | SVP, Chief Accounting Officer | M | Common Stock | 1413 | $163.63 | 3,406.2194 | 83,400,000 | 70.89% | 0.00% |
| Feb. 18, 2025 | Wilkinson Peter J | SVP, Chief Accounting Officer | S | Common Stock | 1413 | $246.10 | 1,993.2194 | 83,400,000 | 41.48% | 0.00% |
| Feb. 11, 2025 | van der Vaart Sandra D | EVP, Chief Legal Officer | A | Non-qualified Stock Options | 3400 | $0.00 | 3,400.0000 | 83,400,000 | 9999.99% | 0.00% |
| Feb. 11, 2025 | Wilkinson Peter J | SVP, Chief Accounting Officer | M | Common Stock | 123 | $0.00 | 2,385.2194 | 83,400,000 | 5.44% | 0.00% |
| Feb. 11, 2025 | Wilkinson Peter J | SVP, Chief Accounting Officer | F | Common Stock | 41 | $245.14 | 2,344.2194 | 83,400,000 | 1.72% | 0.00% |
| Feb. 11, 2025 | Wilkinson Peter J | SVP, Chief Accounting Officer | A | Non-qualified Stock Options | 1500 | $0.00 | 1,500.0000 | 83,400,000 | 9999.99% | 0.00% |
| Feb. 11, 2025 | Wilkinson Peter J | SVP, Chief Accounting Officer | A | Restricted Stock Unit | 480 | $0.00 | 1,004.0000 | 83,400,000 | 91.60% | 0.00% |
| Feb. 11, 2025 | Wilkinson Peter J | SVP, Chief Accounting Officer | A | Restricted Stock Unit | 1610 | $0.00 | 2,614.0000 | 83,400,000 | 160.36% | 0.00% |
| Feb. 11, 2025 | Wilkinson Peter J | SVP, Chief Accounting Officer | M | Restricted Stock Unit | 123 | $0.00 | 2,491.0000 | 83,400,000 | 4.71% | 0.00% |
| Feb. 11, 2025 | Summy Amy B. | EVP, Chief Marketing Officer | M | Common Stock | 201 | $0.00 | 4,825.5000 | 83,400,000 | 4.35% | 0.00% |
| Feb. 11, 2025 | Summy Amy B. | EVP, Chief Marketing Officer | F | Common Stock | 55 | $245.14 | 4,770.5000 | 83,400,000 | 1.14% | 0.00% |
| Feb. 11, 2025 | Summy Amy B. | EVP, Chief Marketing Officer | A | Non-qualified Stock Options | 2100 | $0.00 | 2,100.0000 | 83,400,000 | 9999.99% | 0.00% |
| Feb. 11, 2025 | Summy Amy B. | EVP, Chief Marketing Officer | A | Restricted Stock Unit | 690 | $0.00 | 1,560.0000 | 83,400,000 | 79.31% | 0.00% |
| Feb. 11, 2025 | Summy Amy B. | EVP, Chief Marketing Officer | M | Restricted Stock Unit | 201 | $0.00 | 1,359.0000 | 83,400,000 | 12.88% | 0.00% |
| Feb. 11, 2025 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | A | Non-qualified Stock Options | 3700 | $0.00 | 3,700.0000 | 83,400,000 | 9999.99% | 0.00% |
| Feb. 11, 2025 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | A | Restricted Stock Unit | 1210 | $0.00 | 7,256.0000 | 83,400,000 | 20.01% | 0.00% |
| Feb. 11, 2025 | Schechter Adam H | President & CEO | S | Common Stock | 6121 | $244.62 | 86,445.0000 | 83,400,000 | 6.61% | 0.01% |
| Feb. 11, 2025 | Schechter Adam H | President & CEO | M | Common Stock | 2963 | $0.00 | 89,408.0000 | 83,400,000 | 3.43% | 0.00% |
| Feb. 11, 2025 | Schechter Adam H | President & CEO | F | Common Stock | 1226 | $245.14 | 88,182.0000 | 83,400,000 | 1.37% | 0.00% |
| Feb. 11, 2025 | Schechter Adam H | President & CEO | A | Non-qualified Stock Options | 33100 | $0.00 | 33,100.0000 | 83,400,000 | 9999.99% | 0.04% |
| Feb. 11, 2025 | Schechter Adam H | President & CEO | A | Restricted Stock Unit | 10970 | $0.00 | 26,102.0000 | 83,400,000 | 72.50% | 0.01% |
| Feb. 11, 2025 | Schechter Adam H | President & CEO | M | Restricted Stock Unit | 2963 | $0.00 | 23,139.0000 | 83,400,000 | 11.35% | 0.00% |
| Feb. 11, 2025 | EISENBERG GLENN A | Executive Vice President | M | Common Stock | 807 | $0.00 | 33,458.0000 | 83,400,000 | 2.47% | 0.00% |
| Feb. 11, 2025 | EISENBERG GLENN A | Executive Vice President | F | Common Stock | 213 | $245.14 | 33,245.0000 | 83,400,000 | 0.64% | 0.00% |
| Feb. 11, 2025 | EISENBERG GLENN A | Executive Vice President | M | Restricted Stock Unit | 807 | $0.00 | 2,819.0000 | 83,400,000 | 22.26% | 0.00% |
| Feb. 11, 2025 | BERBERIAN LANCE | EVP, Special Advisor, Strategy | M | Common Stock | 323 | $0.00 | 16,766.0000 | 83,400,000 | 1.96% | 0.00% |
| Feb. 11, 2025 | BERBERIAN LANCE | EVP, Special Advisor, Strategy | F | Common Stock | 86 | $245.14 | 16,680.0000 | 83,400,000 | 0.51% | 0.00% |
| Feb. 11, 2025 | BERBERIAN LANCE | EVP, Special Advisor, Strategy | M | Restricted Stock Unit | 323 | $0.00 | 1,067.0000 | 83,400,000 | 23.24% | 0.00% |
| Feb. 11, 2025 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | M | Common Stock | 473 | $0.00 | 29,471.6573 | 83,400,000 | 1.63% | 0.00% |
| Feb. 11, 2025 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | F | Common Stock | 136 | $245.14 | 29,335.6573 | 83,400,000 | 0.46% | 0.00% |
| Feb. 11, 2025 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | A | Non-qualified Stock Options | 6700 | $0.00 | 6,700.0000 | 83,400,000 | 9999.99% | 0.01% |
| Feb. 11, 2025 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | A | Restricted Stock Unit | 2220 | $0.00 | 4,661.0000 | 83,400,000 | 90.95% | 0.00% |
| Feb. 11, 2025 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | M | Restricted Stock Unit | 473 | $0.00 | 4,188.0000 | 83,400,000 | 10.15% | 0.00% |
| Feb. 11, 2025 | van der Vaart Sandra D | EVP, Chief Legal Officer | M | Common Stock | 323 | $0.00 | 3,570.5397 | 83,400,000 | 9.95% | 0.00% |
| Feb. 11, 2025 | van der Vaart Sandra D | EVP, Chief Legal Officer | F | Common Stock | 86 | $245.14 | 3,484.5397 | 83,400,000 | 2.41% | 0.00% |
| Feb. 11, 2025 | van der Vaart Sandra D | EVP, Chief Legal Officer | A | Restricted Stock Unit | 1130 | $0.00 | 2,580.0000 | 83,400,000 | 77.93% | 0.00% |
| Feb. 11, 2025 | van der Vaart Sandra D | EVP, Chief Legal Officer | M | Restricted Stock Unit | 323 | $0.00 | 2,257.0000 | 83,400,000 | 12.52% | 0.00% |
| Feb. 11, 2025 | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Common Stock | 473 | $0.00 | 6,530.1426 | 83,400,000 | 7.81% | 0.00% |
| Feb. 11, 2025 | Schroeder Mark S | EVP, Pres Diagnostics & COO | F | Common Stock | 134 | $245.14 | 6,396.1426 | 83,400,000 | 2.05% | 0.00% |
| Feb. 11, 2025 | Schroeder Mark S | EVP, Pres Diagnostics & COO | A | Non-qualified Stock Options | 7300 | $0.00 | 7,300.0000 | 83,400,000 | 9999.99% | 0.01% |
| Feb. 11, 2025 | Schroeder Mark S | EVP, Pres Diagnostics & COO | A | Restricted Stock Unit | 2420 | $0.00 | 5,061.0000 | 83,400,000 | 91.63% | 0.00% |
| Feb. 11, 2025 | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Restricted Stock Unit | 473 | $0.00 | 4,588.0000 | 83,400,000 | 9.35% | 0.00% |
| Feb. 11, 2025 | GRAHAM ANITA Z | EVP, CHRO | A | Non-qualified Stock Options | 3200 | $0.00 | 3,200.0000 | 83,400,000 | 9999.99% | 0.00% |
| Feb. 11, 2025 | GRAHAM ANITA Z | EVP, CHRO | A | Restricted Stock Unit | 1070 | $0.00 | 2,091.0000 | 83,400,000 | 104.80% | 0.00% |
| Feb. 11, 2025 | Oyegunwa Akinbolade | EVP, CIO & CTO | M | Common Stock | 134 | $0.00 | 3,016.2530 | 83,400,000 | 4.65% | 0.00% |
| Feb. 11, 2025 | Oyegunwa Akinbolade | EVP, CIO & CTO | F | Common Stock | 42 | $245.14 | 2,974.2530 | 83,400,000 | 1.39% | 0.00% |
| Feb. 11, 2025 | Oyegunwa Akinbolade | EVP, CIO & CTO | A | Non-qualified Stock Options | 2100 | $0.00 | 2,100.0000 | 83,400,000 | 9999.99% | 0.00% |
| Feb. 11, 2025 | Oyegunwa Akinbolade | EVP, CIO & CTO | A | Restricted Stock Unit | 690 | $0.00 | 2,443.0000 | 83,400,000 | 39.36% | 0.00% |
| Feb. 11, 2025 | Oyegunwa Akinbolade | EVP, CIO & CTO | M | Restricted Stock Unit | 134 | $0.00 | 2,309.0000 | 83,400,000 | 5.49% | 0.00% |
| Feb. 11, 2025 | Wang Julia Aijun | Chief Financial Officer, EVP | A | Non-qualified Stock Options | 7800 | $0.00 | 7,800.0000 | 83,400,000 | 9999.99% | 0.01% |
| Feb. 11, 2025 | Wang Julia Aijun | Chief Financial Officer, EVP | A | Restricted Stock Unit | 2580 | $0.00 | 4,367.0000 | 83,400,000 | 144.38% | 0.00% |
| Feb. 11, 2025 | Wengel Kathryn E | Director | A | Restricted Stock Unit | 897 | $0.00 | 897.0000 | 83,400,000 | 9999.99% | 0.00% |
| Feb. 11, 2025 | Rothman Paul | Director | A | Restricted Stock Unit | 897 | $0.00 | 897.0000 | 83,400,000 | 9999.99% | 0.00% |
| Feb. 11, 2025 | Parham Richelle P | Director | A | Restricted Stock Unit | 897 | $0.00 | 897.0000 | 83,400,000 | 9999.99% | 0.00% |
| Feb. 11, 2025 | NEUPERT PETER M | Director | A | Restricted Stock Unit | 897 | $0.00 | 897.0000 | 83,400,000 | 9999.99% | 0.00% |
| Feb. 11, 2025 | Kong Garheng | Director | A | Restricted Stock Unit | 897 | $0.00 | 897.0000 | 83,400,000 | 9999.99% | 0.00% |
| Feb. 11, 2025 | Gilliland Dwight Gary | Director | A | Restricted Stock Unit | 897 | $0.00 | 897.0000 | 83,400,000 | 9999.99% | 0.00% |
| Feb. 11, 2025 | Davis Jeffrey A. | Director | A | Restricted Stock Unit | 897 | $0.00 | 897.0000 | 83,400,000 | 9999.99% | 0.00% |
| Feb. 11, 2025 | ANDERSON KERRII B | Director | A | Restricted Stock Unit | 897 | $0.00 | 897.0000 | 83,400,000 | 9999.99% | 0.00% |
| Feb. 11, 2025 | Kliphouse Kirsten Marie | Director | A | Restricted Stock Unit | 897 | $0.00 | 897.0000 | 83,400,000 | 9999.99% | 0.00% |
| Feb. 7, 2025 | Oyegunwa Akinbolade | EVP, CIO & CTO | F | Common Stock | 51 | $246.27 | 2,882.2530 | 83,400,000 | 1.74% | 0.00% |
| Feb. 6, 2025 | EISENBERG GLENN A | Executive Vice President | M | Common Stock | 966 | $0.00 | 32,255.0000 | 83,400,000 | 3.09% | 0.00% |
| Feb. 6, 2025 | EISENBERG GLENN A | Executive Vice President | F | Common Stock | 255 | $247.74 | 32,000.0000 | 83,400,000 | 0.79% | 0.00% |
| Feb. 7, 2025 | EISENBERG GLENN A | Executive Vice President | M | Common Stock | 885 | $0.00 | 32,885.0000 | 83,400,000 | 2.77% | 0.00% |
| Feb. 7, 2025 | EISENBERG GLENN A | Executive Vice President | F | Common Stock | 234 | $246.27 | 32,651.0000 | 83,400,000 | 0.71% | 0.00% |
| Feb. 6, 2025 | EISENBERG GLENN A | Executive Vice President | M | Restricted Stock Unit | 966 | $0.00 | 4,511.0000 | 83,400,000 | 17.64% | 0.00% |
| Feb. 7, 2025 | EISENBERG GLENN A | Executive Vice President | M | Restricted Stock Unit | 885 | $0.00 | 3,626.0000 | 83,400,000 | 19.62% | 0.00% |
| Feb. 6, 2025 | BERBERIAN LANCE | EVP, Special Advisor, Strategy | M | Common Stock | 356 | $0.00 | 16,277.0000 | 83,400,000 | 2.24% | 0.00% |
| Feb. 6, 2025 | BERBERIAN LANCE | EVP, Special Advisor, Strategy | F | Common Stock | 94 | $247.74 | 16,183.0000 | 83,400,000 | 0.58% | 0.00% |
| Feb. 7, 2025 | BERBERIAN LANCE | EVP, Special Advisor, Strategy | M | Common Stock | 354 | $0.00 | 16,537.0000 | 83,400,000 | 2.19% | 0.00% |
| Feb. 7, 2025 | BERBERIAN LANCE | EVP, Special Advisor, Strategy | F | Common Stock | 94 | $246.27 | 16,443.0000 | 83,400,000 | 0.57% | 0.00% |
| Feb. 6, 2025 | BERBERIAN LANCE | EVP, Special Advisor, Strategy | M | Restricted Stock Unit | 356 | $0.00 | 1,744.0000 | 83,400,000 | 16.95% | 0.00% |
| Feb. 7, 2025 | BERBERIAN LANCE | EVP, Special Advisor, Strategy | M | Restricted Stock Unit | 354 | $0.00 | 1,390.0000 | 83,400,000 | 20.30% | 0.00% |
| Feb. 6, 2025 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | M | Common Stock | 670 | $0.00 | 28,763.6573 | 83,400,000 | 2.38% | 0.00% |
| Feb. 6, 2025 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | F | Common Stock | 212 | $247.74 | 28,551.6573 | 83,400,000 | 0.74% | 0.00% |
| Feb. 7, 2025 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | M | Common Stock | 517 | $0.00 | 29,068.6573 | 83,400,000 | 1.81% | 0.00% |
| Feb. 7, 2025 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | F | Common Stock | 149 | $246.27 | 28,919.6573 | 83,400,000 | 0.51% | 0.00% |
| Feb. 7, 2025 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | M | Common Stock | 112 | $0.00 | 29,031.6573 | 83,400,000 | 0.39% | 0.00% |
| Feb. 7, 2025 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | F | Common Stock | 33 | $246.27 | 28,998.6573 | 83,400,000 | 0.11% | 0.00% |
| Feb. 6, 2025 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | M | Restricted Stock Unit | 670 | $0.00 | 3,070.0000 | 83,400,000 | 17.91% | 0.00% |
| Feb. 7, 2025 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | M | Restricted Stock Unit | 517 | $0.00 | 2,553.0000 | 83,400,000 | 16.84% | 0.00% |
| Feb. 7, 2025 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | M | Restricted Stock Unit | 112 | $0.00 | 2,441.0000 | 83,400,000 | 4.39% | 0.00% |
| Feb. 6, 2025 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | M | Common Stock | 180 | $0.00 | 616.0000 | 83,400,000 | 41.28% | 0.00% |
| Feb. 6, 2025 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | F | Common Stock | 70 | $247.74 | 546.0000 | 83,400,000 | 11.36% | 0.00% |
| Feb. 7, 2025 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | M | Common Stock | 224 | $0.00 | 770.0000 | 83,400,000 | 41.03% | 0.00% |
| Feb. 7, 2025 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | F | Common Stock | 85 | $246.27 | 685.0000 | 83,400,000 | 11.04% | 0.00% |
| Feb. 7, 2025 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | M | Common Stock | 67 | $0.00 | 752.0000 | 83,400,000 | 9.78% | 0.00% |
| Feb. 7, 2025 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | F | Common Stock | 22 | $246.27 | 730.0000 | 83,400,000 | 2.93% | 0.00% |
| Feb. 6, 2025 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | M | Restricted Stock Unit | 180 | $0.00 | 6,337.0000 | 83,400,000 | 2.76% | 0.00% |
| Feb. 7, 2025 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | M | Restricted Stock Unit | 224 | $0.00 | 6,113.0000 | 83,400,000 | 3.53% | 0.00% |
| Feb. 7, 2025 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | M | Restricted Stock Unit | 67 | $0.00 | 6,046.0000 | 83,400,000 | 1.10% | 0.00% |
| Feb. 6, 2025 | Oyegunwa Akinbolade | EVP, CIO & CTO | M | Common Stock | 180 | $0.00 | 2,846.2530 | 83,400,000 | 6.75% | 0.00% |
| Feb. 6, 2025 | Oyegunwa Akinbolade | EVP, CIO & CTO | F | Common Stock | 62 | $247.74 | 2,784.2530 | 83,400,000 | 2.18% | 0.00% |
| Feb. 7, 2025 | Oyegunwa Akinbolade | EVP, CIO & CTO | M | Common Stock | 149 | $0.00 | 2,933.2530 | 83,400,000 | 5.35% | 0.00% |
| Feb. 7, 2025 | Wilkinson Peter J | SVP, Chief Accounting Officer | M | Common Stock | 134 | $0.00 | 2,308.2194 | 83,400,000 | 6.16% | 0.00% |
| Feb. 7, 2025 | Wilkinson Peter J | SVP, Chief Accounting Officer | F | Common Stock | 46 | $246.27 | 2,262.2194 | 83,400,000 | 1.99% | 0.00% |
| Feb. 6, 2025 | Wilkinson Peter J | SVP, Chief Accounting Officer | M | Restricted Stock Unit | 133 | $0.00 | 658.0000 | 83,400,000 | 16.81% | 0.00% |
| Feb. 7, 2025 | Wilkinson Peter J | SVP, Chief Accounting Officer | M | Restricted Stock Unit | 134 | $0.00 | 524.0000 | 83,400,000 | 20.36% | 0.00% |
| Feb. 6, 2025 | Schechter Adam H | President & CEO | M | Common Stock | 4460 | $0.00 | 91,901.0000 | 83,400,000 | 5.10% | 0.01% |
| Feb. 6, 2025 | Schechter Adam H | President & CEO | F | Common Stock | 1240 | $247.74 | 90,661.0000 | 83,400,000 | 1.35% | 0.00% |
| Feb. 7, 2025 | Schechter Adam H | President & CEO | M | Common Stock | 3250 | $0.00 | 93,911.0000 | 83,400,000 | 3.58% | 0.00% |
| Feb. 7, 2025 | Schechter Adam H | President & CEO | F | Common Stock | 1345 | $246.27 | 92,566.0000 | 83,400,000 | 1.43% | 0.00% |
| Feb. 6, 2025 | Schechter Adam H | President & CEO | M | Restricted Stock Unit | 4460 | $0.00 | 18,382.0000 | 83,400,000 | 19.53% | 0.01% |
| Feb. 7, 2025 | Schechter Adam H | President & CEO | M | Restricted Stock Unit | 3250 | $0.00 | 15,132.0000 | 83,400,000 | 17.68% | 0.00% |
| Feb. 6, 2025 | van der Vaart Sandra D | EVP, Chief Legal Officer | M | Common Stock | 386 | $0.00 | 3,089.5397 | 83,400,000 | 14.28% | 0.00% |
| Feb. 6, 2025 | van der Vaart Sandra D | EVP, Chief Legal Officer | F | Common Stock | 102 | $247.74 | 2,987.5397 | 83,400,000 | 3.30% | 0.00% |
| Feb. 7, 2025 | van der Vaart Sandra D | EVP, Chief Legal Officer | M | Common Stock | 354 | $0.00 | 3,341.5397 | 83,400,000 | 11.85% | 0.00% |
| Feb. 7, 2025 | van der Vaart Sandra D | EVP, Chief Legal Officer | F | Common Stock | 94 | $246.27 | 3,247.5397 | 83,400,000 | 2.81% | 0.00% |
| Feb. 6, 2025 | van der Vaart Sandra D | EVP, Chief Legal Officer | M | Restricted Stock Unit | 386 | $0.00 | 1,804.0000 | 83,400,000 | 17.63% | 0.00% |
| Feb. 7, 2025 | van der Vaart Sandra D | EVP, Chief Legal Officer | M | Restricted Stock Unit | 354 | $0.00 | 1,450.0000 | 83,400,000 | 19.62% | 0.00% |
| Feb. 6, 2025 | GRAHAM ANITA Z | EVP, CHRO | M | Common Stock | 326 | $0.00 | 618.0000 | 83,400,000 | 111.64% | 0.00% |
| Feb. 6, 2025 | GRAHAM ANITA Z | EVP, CHRO | F | Common Stock | 118 | $247.74 | 500.0000 | 83,400,000 | 19.09% | 0.00% |
| Feb. 7, 2025 | GRAHAM ANITA Z | EVP, CHRO | M | Common Stock | 369 | $0.00 | 869.0000 | 83,400,000 | 73.80% | 0.00% |
| Feb. 7, 2025 | GRAHAM ANITA Z | EVP, CHRO | F | Common Stock | 119 | $246.27 | 750.0000 | 83,400,000 | 13.69% | 0.00% |
| Feb. 6, 2025 | GRAHAM ANITA Z | EVP, CHRO | M | Restricted Stock Unit | 326 | $0.00 | 1,390.0000 | 83,400,000 | 19.00% | 0.00% |
| Feb. 7, 2025 | GRAHAM ANITA Z | EVP, CHRO | M | Restricted Stock Unit | 369 | $0.00 | 1,021.0000 | 83,400,000 | 26.55% | 0.00% |
| Feb. 6, 2025 | Wang Julia Aijun | Chief Financial Officer, EVP | M | Common Stock | 893 | $0.00 | 893.0000 | 83,400,000 | 9999.99% | 0.00% |
| Feb. 6, 2025 | Wang Julia Aijun | Chief Financial Officer, EVP | F | Common Stock | 336 | $247.74 | 557.0000 | 83,400,000 | 37.63% | 0.00% |
| Feb. 6, 2025 | Wang Julia Aijun | Chief Financial Officer, EVP | M | Restricted Stock Unit | 893 | $0.00 | 1,787.0000 | 83,400,000 | 33.32% | 0.00% |
| Feb. 6, 2025 | Wengel Kathryn E | Director | M | Common Stock | 944 | $0.00 | 3,236.0000 | 83,400,000 | 41.19% | 0.00% |
| Feb. 6, 2025 | Wengel Kathryn E | Director | M | Restricted Stock Unit | 944 | $0.00 | 0.0000 | 83,400,000 | 100.00% | 0.00% |
| Feb. 6, 2025 | Parham Richelle P | Director | M | Common Stock | 944 | $0.00 | 9,478.0000 | 83,400,000 | 11.06% | 0.00% |
| Feb. 6, 2025 | Parham Richelle P | Director | M | Restricted Stock Unit | 944 | $0.00 | 0.0000 | 83,400,000 | 100.00% | 0.00% |
| Feb. 6, 2025 | NEUPERT PETER M | Director | M | Common Stock | 944 | $0.00 | 12,887.0000 | 83,400,000 | 7.90% | 0.00% |
| Feb. 6, 2025 | NEUPERT PETER M | Director | M | Restricted Stock Unit | 944 | $0.00 | 0.0000 | 83,400,000 | 100.00% | 0.00% |
| Feb. 6, 2025 | Kong Garheng | Director | M | Common Stock | 944 | $0.00 | 12,842.0000 | 83,400,000 | 7.93% | 0.00% |
| Feb. 6, 2025 | Kong Garheng | Director | M | Restricted Stock Unit | 944 | $0.00 | 0.0000 | 83,400,000 | 100.00% | 0.00% |
| Feb. 6, 2025 | Davis Jeffrey A. | Director | M | Common Stock | 944 | $0.00 | 4,563.0000 | 83,400,000 | 26.08% | 0.00% |
| Feb. 6, 2025 | Davis Jeffrey A. | Director | M | Restricted Stock Unit | 944 | $0.00 | 0.0000 | 83,400,000 | 100.00% | 0.00% |
| Feb. 6, 2025 | Kliphouse Kirsten Marie | Director | M | Common Stock | 944 | $0.00 | 2,263.0000 | 83,400,000 | 71.57% | 0.00% |
| Feb. 6, 2025 | Kliphouse Kirsten Marie | Director | M | Restricted Stock Unit | 944 | $0.00 | 0.0000 | 83,400,000 | 100.00% | 0.00% |
| Feb. 6, 2025 | ANDERSON KERRII B | Director | M | Common Stock | 944 | $0.00 | 13,954.0000 | 83,400,000 | 7.26% | 0.00% |
| Feb. 6, 2025 | ANDERSON KERRII B | Director | M | Restricted Stock Unit | 944 | $0.00 | 0.0000 | 83,400,000 | 100.00% | 0.00% |
| Feb. 6, 2025 | Rothman Paul | Director | M | Common Stock | 944 | $0.00 | 1,674.0000 | 83,400,000 | 129.32% | 0.00% |
| Feb. 6, 2025 | Rothman Paul | Director | M | Restricted Stock Unit | 944 | $0.00 | 0.0000 | 83,400,000 | 100.00% | 0.00% |
| Feb. 6, 2025 | Gilliland Dwight Gary | Director | M | Common Stock | 944 | $0.00 | 8,656.0000 | 83,400,000 | 12.24% | 0.00% |
| Feb. 6, 2025 | Gilliland Dwight Gary | Director | M | Restricted Stock Unit | 944 | $0.00 | 0.0000 | 83,400,000 | 100.00% | 0.00% |
| Feb. 6, 2025 | Oyegunwa Akinbolade | EVP, CIO & CTO | M | Restricted Stock Unit | 180 | $0.00 | 1,902.0000 | 83,400,000 | 8.65% | 0.00% |
| Feb. 7, 2025 | Oyegunwa Akinbolade | EVP, CIO & CTO | M | Restricted Stock Unit | 149 | $0.00 | 1,753.0000 | 83,400,000 | 7.83% | 0.00% |
| Feb. 6, 2025 | Summy Amy B. | EVP, Chief Marketing Officer | M | Common Stock | 223 | $0.00 | 4,541.5000 | 83,400,000 | 5.16% | 0.00% |
| Feb. 6, 2025 | Summy Amy B. | EVP, Chief Marketing Officer | F | Common Stock | 73 | $247.74 | 4,468.5000 | 83,400,000 | 1.61% | 0.00% |
| Feb. 7, 2025 | Summy Amy B. | EVP, Chief Marketing Officer | M | Common Stock | 224 | $0.00 | 4,692.5000 | 83,400,000 | 5.01% | 0.00% |
| Feb. 7, 2025 | Summy Amy B. | EVP, Chief Marketing Officer | F | Common Stock | 68 | $246.27 | 4,624.5000 | 83,400,000 | 1.45% | 0.00% |
| Feb. 6, 2025 | Summy Amy B. | EVP, Chief Marketing Officer | M | Restricted Stock Unit | 223 | $0.00 | 1,094.0000 | 83,400,000 | 16.93% | 0.00% |
| Feb. 7, 2025 | Summy Amy B. | EVP, Chief Marketing Officer | M | Restricted Stock Unit | 224 | $0.00 | 870.0000 | 83,400,000 | 20.48% | 0.00% |
| Feb. 6, 2025 | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Common Stock | 743 | $0.00 | 5,779.1426 | 83,400,000 | 14.75% | 0.00% |
| Feb. 6, 2025 | Schroeder Mark S | EVP, Pres Diagnostics & COO | F | Common Stock | 210 | $247.74 | 5,569.1426 | 83,400,000 | 3.63% | 0.00% |
| Feb. 7, 2025 | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Common Stock | 517 | $0.00 | 6,086.1426 | 83,400,000 | 9.28% | 0.00% |
| Feb. 7, 2025 | Schroeder Mark S | EVP, Pres Diagnostics & COO | F | Common Stock | 146 | $246.27 | 5,940.1426 | 83,400,000 | 2.40% | 0.00% |
| Feb. 7, 2025 | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Common Stock | 164 | $0.00 | 6,104.1426 | 83,400,000 | 2.76% | 0.00% |
| Feb. 7, 2025 | Schroeder Mark S | EVP, Pres Diagnostics & COO | F | Common Stock | 47 | $246.27 | 6,057.1426 | 83,400,000 | 0.77% | 0.00% |
| Feb. 6, 2025 | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Restricted Stock Unit | 743 | $0.00 | 3,322.0000 | 83,400,000 | 18.28% | 0.00% |
| Feb. 7, 2025 | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Restricted Stock Unit | 517 | $0.00 | 2,805.0000 | 83,400,000 | 15.56% | 0.00% |
| Feb. 7, 2025 | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Restricted Stock Unit | 164 | $0.00 | 2,641.0000 | 83,400,000 | 5.85% | 0.00% |
| Feb. 6, 2025 | Wilkinson Peter J | SVP, Chief Accounting Officer | M | Common Stock | 133 | $0.00 | 2,220.2194 | 83,400,000 | 6.37% | 0.00% |
| Feb. 6, 2025 | Wilkinson Peter J | SVP, Chief Accounting Officer | F | Common Stock | 46 | $247.74 | 2,174.2194 | 83,400,000 | 2.07% | 0.00% |
| Jan. 7, 2025 | ANDERSON KERRII B | Director | S | Common Stock | 1000 | $235.00 | 13,010.0000 | 83,400,000 | 7.14% | 0.00% |
| Dec. 2, 2024 | Wang Julia Aijun | Chief Financial Officer, EVP | A | Non-qualified Stock Options | 8100 | $0.00 | 8,100.0000 | 83,900,000 | 9999.99% | 0.01% |
| Dec. 2, 2024 | Gilliland Dwight Gary | Director | S | Common Stock | 1000 | $241.00 | 7,712.0000 | 83,900,000 | 11.48% | 0.00% |
| Dec. 2, 2024 | EISENBERG GLENN A | Executive Vice President | M | Non-qualified Stock Options | 2788 | $0.00 | 5,577.0000 | 83,900,000 | 33.33% | 0.00% |
| Dec. 2, 2024 | EISENBERG GLENN A | Executive Vice President | M | Non-qualified Stock Options | 8923 | $0.00 | 0.0000 | 83,900,000 | 100.00% | 0.01% |
| Dec. 2, 2024 | EISENBERG GLENN A | Executive Vice President | S | Common Stock | 11711 | $240.43 | 31,289.0000 | 83,900,000 | 27.23% | 0.01% |
| Dec. 2, 2024 | EISENBERG GLENN A | Executive Vice President | M | Common Stock | 2788 | $221.67 | 43,000.0000 | 83,900,000 | 6.93% | 0.00% |
| Dec. 2, 2024 | EISENBERG GLENN A | Executive Vice President | M | Common Stock | 8923 | $209.25 | 40,212.0000 | 83,900,000 | 28.52% | 0.01% |
| Dec. 2, 2024 | Wang Julia Aijun | Chief Financial Officer, EVP | A | Restricted Stock Unit | 2680 | $0.00 | 2,680.0000 | 83,900,000 | 9999.99% | 0.00% |
| Nov. 22, 2024 | Summy Amy B. | EVP, Chief Marketing Officer | M | Non-qualified Stock Options | 4015 | $0.00 | 0.0000 | 83,900,000 | 100.00% | 0.00% |
| Nov. 22, 2024 | Summy Amy B. | EVP, Chief Marketing Officer | S | Common Stock | 3672 | $238.91 | 4,318.5000 | 83,900,000 | 45.95% | 0.00% |
| Nov. 22, 2024 | Summy Amy B. | EVP, Chief Marketing Officer | M | Common Stock | 4015 | $168.52 | 7,990.0000 | 83,900,000 | 101.01% | 0.00% |
| Nov. 21, 2024 | van der Vaart Sandra D | EVP, Chief Legal Officer | S | Common Stock | 1000 | $239.42 | 2,669.8470 | 83,900,000 | 27.25% | 0.00% |
| Nov. 11, 2024 | Schechter Adam H | President & CEO | S | Common Stock | 6189 | $243.47 | 87,441.0000 | 83,900,000 | 6.61% | 0.01% |
| Nov. 1, 2024 | Oyegunwa Akinbolade | EVP, CIO & CTO | A | Restricted Stock Unit | 1110 | $0.00 | 2,082.0000 | 83,900,000 | 114.20% | 0.00% |
| Nov. 1, 2024 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | A | Restricted Stock Unit | 1110 | $0.00 | 6,517.0000 | 83,900,000 | 20.53% | 0.00% |
| Oct. 24, 2024 | ANDERSON KERRII B | Director | S | Common Stock | 1000 | $230.00 | 14,010.0000 | 83,900,000 | 6.66% | 0.00% |
| Aug. 19, 2024 | van der Vaart Sandra D | EVP, Chief Legal Officer | S | Common Stock | 2000 | $227.05 | 3,669.8470 | 83,900,000 | 35.27% | 0.00% |
| Aug. 15, 2024 | EISENBERG GLENN A | Chief Financial Officer, EVP | S | Common Stock | 9071 | $224.55 | 31,289.0000 | 83,900,000 | 22.48% | 0.01% |
| Aug. 15, 2024 | EISENBERG GLENN A | Chief Financial Officer, EVP | S | Common Stock | 2950 | $223.62 | 40,360.0000 | 83,900,000 | 6.81% | 0.00% |
| Aug. 15, 2024 | EISENBERG GLENN A | Chief Financial Officer, EVP | S | Common Stock | 2979 | $222.65 | 43,310.0000 | 83,900,000 | 6.44% | 0.00% |
| Aug. 8, 2024 | ANDERSON KERRII B | Director | S | Common Stock | 586 | $225.00 | 15,010.0000 | 83,900,000 | 3.76% | 0.00% |
| Aug. 7, 2024 | ANDERSON KERRII B | Director | S | Common Stock | 414 | $225.00 | 15,596.0000 | 83,900,000 | 2.59% | 0.00% |
| Aug. 5, 2024 | BERBERIAN LANCE | EVP, CIO & CTO | S | Common Stock | 2245 | $229.79 | 25,769.0000 | 83,900,000 | 8.01% | 0.00% |
| Aug. 5, 2024 | BERBERIAN LANCE | EVP, CIO & CTO | S | Common Stock | 9848 | $228.95 | 15,921.0000 | 83,900,000 | 38.22% | 0.01% |
| June 6, 2024 | Rothman Paul | Director | M | Common Stock | 717 | $0.00 | 717.0000 | 83,900,000 | 9999.99% | 0.00% |
| June 6, 2024 | Rothman Paul | Director | M | Restricted Stock Unit | 717 | $0.00 | 944.0000 | 83,900,000 | 43.17% | 0.00% |
| May 14, 2024 | van der Vaart Sandra D | EVP, Chief Legal Officer | S | Common Stock | 200 | $210.84 | 5,636.9790 | 83,900,000 | 3.43% | 0.00% |
| May 14, 2024 | van der Vaart Sandra D | EVP, Chief Legal Officer | S | Common Stock | 1800 | $210.83 | 5,836.9790 | 83,900,000 | 23.57% | 0.00% |
| April 30, 2024 | ANDERSON KERRII B | Director | S | Common Stock | 250 | $204.14 | 16,260.0000 | 83,900,000 | 1.51% | 0.00% |
| April 30, 2024 | EISENBERG GLENN A | Chief Financial Officer, EVP | M | Common Stock | 10229 | $0.00 | 50,785.0000 | 83,900,000 | 25.22% | 0.01% |
| April 30, 2024 | EISENBERG GLENN A | Chief Financial Officer, EVP | F | Common Stock | 4496 | $201.37 | 46,289.0000 | 83,900,000 | 8.85% | 0.01% |
| April 30, 2024 | EISENBERG GLENN A | Chief Financial Officer, EVP | M | Performance Share Unit | 10229 | $0.00 | 0.0000 | 83,900,000 | 100.00% | 0.01% |
| May 2, 2024 | ANDERSON KERRII B | Director | S | Common Stock | 250 | $200.10 | 16,010.0000 | 83,900,000 | 1.54% | 0.00% |
| April 29, 2024 | Wilkinson Peter J | SVP, Chief Accounting Officer | S | Common Stock | 2439 | $204.33 | 2,087.2194 | 83,900,000 | 53.89% | 0.00% |
| April 15, 2024 | EISENBERG GLENN A | Chief Financial Officer, EVP | M | Common Stock | 10229 | $0.00 | 45,052.0000 | 83,900,000 | 29.37% | 0.01% |
| April 15, 2024 | EISENBERG GLENN A | Chief Financial Officer, EVP | M | Restricted Stock Unit | 10229 | $0.00 | 5,477.0000 | 83,900,000 | 65.13% | 0.01% |
| April 15, 2024 | EISENBERG GLENN A | Chief Financial Officer, EVP | F | Common Stock | 4496 | $203.32 | 40,556.0000 | 83,900,000 | 9.98% | 0.01% |
| April 1, 2024 | Bailey Megan D. | EVP, Chief Strategy Officer | M | Common Stock | 205 | $0.00 | 505.0000 | 83,900,000 | 68.33% | 0.00% |
| April 1, 2024 | Bailey Megan D. | EVP, Chief Strategy Officer | F | Common Stock | 69 | $216.35 | 436.0000 | 83,900,000 | 13.66% | 0.00% |
| April 1, 2024 | Bailey Megan D. | EVP, Chief Strategy Officer | M | Restricted Stock Unit | 205 | $0.00 | 5,407.0000 | 83,900,000 | 3.65% | 0.00% |
| April 1, 2024 | Schroeder Mark S | EVP, Pres Diagnostics & COO | S | Common Stock | 6477 | $217.29 | 5,036.1426 | 83,900,000 | 56.26% | 0.01% |
| April 1, 2024 | Summy Amy B. | EVP, Chief Marketing Officer | S | Common Stock | 3500 | $217.29 | 3,975.0000 | 83,900,000 | 46.82% | 0.00% |
| March 27, 2024 | BERBERIAN LANCE | EVP, CIO & CTO | M | Restricted Stock Unit | 7697 | $0.00 | 2,100.0000 | 83,900,000 | 78.56% | 0.01% |
| March 27, 2024 | BERBERIAN LANCE | EVP, CIO & CTO | F | Common Stock | 3299 | $216.57 | 28,014.0000 | 83,900,000 | 10.54% | 0.00% |
| March 27, 2024 | BERBERIAN LANCE | EVP, CIO & CTO | M | Common Stock | 7697 | $0.00 | 31,313.0000 | 83,900,000 | 32.59% | 0.01% |
| March 27, 2024 | EISENBERG GLENN A | Chief Financial Officer, EVP | M | Restricted Stock Unit | 20033 | $0.00 | 15,706.0000 | 83,900,000 | 56.05% | 0.02% |
| March 27, 2024 | EISENBERG GLENN A | Chief Financial Officer, EVP | F | Common Stock | 8805 | $216.57 | 34,823.0000 | 83,900,000 | 20.18% | 0.01% |
| March 27, 2024 | EISENBERG GLENN A | Chief Financial Officer, EVP | M | Common Stock | 20033 | $0.00 | 43,628.0000 | 83,900,000 | 84.90% | 0.02% |
| March 27, 2024 | Summy Amy B. | EVP, Chief Marketing Officer | M | Restricted Stock Unit | 5778 | $0.00 | 1,317.0000 | 83,900,000 | 81.44% | 0.01% |
| March 27, 2024 | Summy Amy B. | EVP, Chief Marketing Officer | F | Common Stock | 2162 | $216.57 | 7,475.0000 | 83,900,000 | 22.43% | 0.00% |
| March 27, 2024 | Summy Amy B. | EVP, Chief Marketing Officer | M | Common Stock | 5778 | $0.00 | 9,637.0000 | 83,900,000 | 149.73% | 0.01% |
| March 27, 2024 | Wilkinson Peter J | SVP, Chief Accounting Officer | M | Restricted Stock Unit | 3079 | $0.00 | 791.0000 | 83,900,000 | 79.56% | 0.00% |
| March 27, 2024 | Wilkinson Peter J | SVP, Chief Accounting Officer | F | Common Stock | 894 | $216.57 | 4,526.2194 | 83,900,000 | 16.49% | 0.00% |
| March 27, 2024 | Wilkinson Peter J | SVP, Chief Accounting Officer | M | Common Stock | 3079 | $0.00 | 5,420.2194 | 83,900,000 | 131.51% | 0.00% |
| March 27, 2024 | DiVincenzo Jonathan P. | EVP, Pres, Central Labs & Intl | M | Restricted Stock Unit | 3012 | $0.00 | 1,965.0000 | 83,900,000 | 60.52% | 0.00% |
| March 27, 2024 | DiVincenzo Jonathan P. | EVP, Pres, Central Labs & Intl | F | Common Stock | 952 | $216.57 | 5,460.5491 | 83,900,000 | 14.85% | 0.00% |
| March 27, 2024 | DiVincenzo Jonathan P. | EVP, Pres, Central Labs & Intl | M | Common Stock | 3012 | $0.00 | 6,412.5491 | 83,900,000 | 88.57% | 0.00% |
| March 27, 2024 | Schechter Adam H | President and CEO | M | Restricted Stock Unit | 72435 | $0.00 | 22,842.0000 | 83,900,000 | 76.03% | 0.09% |
| March 27, 2024 | Schechter Adam H | President and CEO | F | Common Stock | 31799 | $216.57 | 93,630.0000 | 83,900,000 | 25.35% | 0.04% |
| March 27, 2024 | Schechter Adam H | President and CEO | M | Common Stock | 72435 | $0.00 | 125,429.0000 | 83,900,000 | 136.69% | 0.09% |
| March 27, 2024 | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Restricted Stock Unit | 11556 | $0.00 | 4,065.0000 | 83,900,000 | 73.98% | 0.01% |
| March 27, 2024 | Schroeder Mark S | EVP, Pres Diagnostics & COO | F | Common Stock | 5079 | $216.57 | 11,513.1426 | 83,900,000 | 30.61% | 0.01% |
| March 27, 2024 | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Common Stock | 11556 | $0.00 | 16,592.1426 | 83,900,000 | 229.46% | 0.01% |
| March 27, 2024 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | M | Restricted Stock Unit | 11556 | $0.00 | 3,740.0000 | 83,900,000 | 75.55% | 0.01% |
| March 27, 2024 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | F | Common Stock | 5061 | $216.57 | 27,881.0428 | 83,900,000 | 15.36% | 0.01% |
| March 27, 2024 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | M | Common Stock | 11556 | $0.00 | 32,942.0428 | 83,900,000 | 54.04% | 0.01% |
| March 27, 2024 | van der Vaart Sandra D | EVP, Chief Legal Officer | M | Restricted Stock Unit | 6158 | $0.00 | 2,190.0000 | 83,900,000 | 73.77% | 0.01% |
| March 28, 2024 | van der Vaart Sandra D | EVP, Chief Legal Officer | S | Common Stock | 3553 | $216.74 | 7,636.9790 | 83,900,000 | 31.75% | 0.00% |
| March 27, 2024 | van der Vaart Sandra D | EVP, Chief Legal Officer | F | Common Stock | 2605 | $216.57 | 11,189.9790 | 83,900,000 | 18.88% | 0.00% |
| March 27, 2024 | van der Vaart Sandra D | EVP, Chief Legal Officer | M | Common Stock | 6158 | $0.00 | 13,794.9790 | 83,900,000 | 80.63% | 0.01% |
| March 7, 2024 | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Non-qualified Stock Options | 2119 | $0.00 | 0.0000 | 83,900,000 | 100.00% | 0.00% |
| March 7, 2024 | Summy Amy B. | EVP, Chief Marketing Officer | S | Common Stock | 227 | $218.45 | 3,859.0000 | 83,900,000 | 5.56% | 0.00% |
| March 7, 2024 | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Common Stock | 2119 | $117.09 | 10,084.1426 | 83,900,000 | 26.60% | 0.00% |
| March 7, 2024 | Schroeder Mark S | EVP, Pres Diagnostics & COO | S | Common Stock | 5048 | $218.45 | 5,036.1426 | 83,900,000 | 50.06% | 0.01% |
| Feb. 21, 2024 | EISENBERG GLENN A | Chief Financial Officer, EVP | S | Common Stock | 6665 | $217.52 | 25,148.0000 | 83,900,000 | 20.95% | 0.01% |
| Feb. 21, 2024 | EISENBERG GLENN A | Chief Financial Officer, EVP | S | Common Stock | 1553 | $217.98 | 23,595.0000 | 83,900,000 | 6.18% | 0.00% |
| Feb. 21, 2024 | EISENBERG GLENN A | Chief Financial Officer, EVP | M | Non-qualified Stock Options | 14054 | $0.00 | 0.0000 | 83,900,000 | 100.00% | 0.02% |
| Feb. 21, 2024 | DiVincenzo Jonathan P. | EVP, Pres, Central Labs & Intl | S | Common Stock | 500 | $215.49 | 3,400.5491 | 83,900,000 | 12.82% | 0.00% |
| Feb. 21, 2024 | EISENBERG GLENN A | Chief Financial Officer, EVP | M | Common Stock | 14054 | $163.63 | 58,099.0000 | 83,900,000 | 31.91% | 0.02% |
| Feb. 21, 2024 | EISENBERG GLENN A | Chief Financial Officer, EVP | S | Common Stock | 18379 | $215.37 | 39,720.0000 | 83,900,000 | 31.63% | 0.02% |
| Feb. 21, 2024 | EISENBERG GLENN A | Chief Financial Officer, EVP | S | Common Stock | 7907 | $215.68 | 31,813.0000 | 83,900,000 | 19.91% | 0.01% |
| Feb. 13, 2024 | van der Vaart Sandra D | EVP, Chief Legal Officer | S | Common Stock | 237 | $226.45 | 7,636.9790 | 83,900,000 | 3.01% | 0.00% |
| Feb. 11, 2024 | BERBERIAN LANCE | EVP, CIO & CTO | M | Restricted Stock Unit | 324 | $0.00 | 9,797.0000 | 83,900,000 | 3.20% | 0.00% |
| Feb. 11, 2024 | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Restricted Stock Unit | 472 | $0.00 | 15,621.0000 | 83,900,000 | 2.93% | 0.00% |
| Feb. 11, 2024 | Summy Amy B. | EVP, Chief Marketing Officer | M | Common Stock | 201 | $0.00 | 4,152.0000 | 83,900,000 | 5.09% | 0.00% |
| Feb. 12, 2024 | Summy Amy B. | EVP, Chief Marketing Officer | F | Common Stock | 66 | $227.45 | 4,086.0000 | 83,900,000 | 1.59% | 0.00% |
| Feb. 11, 2024 | Summy Amy B. | EVP, Chief Marketing Officer | M | Restricted Stock Unit | 201 | $0.00 | 7,095.0000 | 83,900,000 | 2.75% | 0.00% |
| Feb. 11, 2024 | van der Vaart Sandra D | EVP, Chief Legal Officer | M | Common Stock | 324 | $0.00 | 7,960.9790 | 83,900,000 | 4.24% | 0.00% |
| Feb. 12, 2024 | van der Vaart Sandra D | EVP, Chief Legal Officer | F | Common Stock | 87 | $227.45 | 7,873.9790 | 83,900,000 | 1.09% | 0.00% |
| Feb. 11, 2024 | van der Vaart Sandra D | EVP, Chief Legal Officer | M | Restricted Stock Unit | 324 | $0.00 | 8,348.0000 | 83,900,000 | 3.74% | 0.00% |
| Feb. 11, 2024 | Wilkinson Peter J | SVP, Chief Accounting Officer | M | Common Stock | 123 | $0.00 | 2,384.2194 | 83,900,000 | 5.44% | 0.00% |
| Feb. 12, 2024 | Wilkinson Peter J | SVP, Chief Accounting Officer | F | Common Stock | 43 | $227.45 | 2,341.2194 | 83,900,000 | 1.80% | 0.00% |
| Feb. 11, 2024 | Wilkinson Peter J | SVP, Chief Accounting Officer | M | Restricted Stock Unit | 123 | $0.00 | 3,870.0000 | 83,900,000 | 3.08% | 0.00% |
| Feb. 11, 2024 | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Common Stock | 472 | $0.00 | 8,091.1426 | 83,900,000 | 6.19% | 0.00% |
| Feb. 12, 2024 | Schroeder Mark S | EVP, Pres Diagnostics & COO | F | Common Stock | 126 | $227.45 | 7,965.1426 | 83,900,000 | 1.56% | 0.00% |
| Feb. 11, 2024 | Schechter Adam H | President & CEO | M | Common Stock | 2964 | $0.00 | 54,225.0000 | 83,900,000 | 5.78% | 0.00% |
| Feb. 12, 2024 | Schechter Adam H | President & CEO | F | Common Stock | 1231 | $227.45 | 52,994.0000 | 83,900,000 | 2.27% | 0.00% |
| Feb. 11, 2024 | Schechter Adam H | President & CEO | M | Restricted Stock Unit | 2964 | $0.00 | 95,277.0000 | 83,900,000 | 3.02% | 0.00% |
| Feb. 11, 2024 | EISENBERG GLENN A | Chief Financial Officer, EVP | M | Common Stock | 807 | $0.00 | 44,260.0000 | 83,900,000 | 1.86% | 0.00% |
| Feb. 12, 2024 | EISENBERG GLENN A | Chief Financial Officer, EVP | F | Common Stock | 215 | $227.45 | 44,045.0000 | 83,900,000 | 0.49% | 0.00% |
| Feb. 11, 2024 | EISENBERG GLENN A | Chief Financial Officer, EVP | M | Restricted Stock Unit | 807 | $0.00 | 35,739.0000 | 83,900,000 | 2.21% | 0.00% |
| Feb. 11, 2024 | DiVincenzo Jonathan P. | EVP, Pres, Central Labs & Intl | M | Common Stock | 201 | $0.00 | 3,959.5491 | 83,900,000 | 5.35% | 0.00% |
| Feb. 12, 2024 | DiVincenzo Jonathan P. | EVP, Pres, Central Labs & Intl | F | Common Stock | 59 | $227.45 | 3,900.5491 | 83,900,000 | 1.49% | 0.00% |
| Feb. 11, 2024 | DiVincenzo Jonathan P. | EVP, Pres, Central Labs & Intl | M | Restricted Stock Unit | 201 | $0.00 | 4,977.0000 | 83,900,000 | 3.88% | 0.00% |
| Feb. 11, 2024 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | M | Common Stock | 472 | $0.00 | 21,523.0428 | 83,900,000 | 2.24% | 0.00% |
| Feb. 12, 2024 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | F | Common Stock | 137 | $227.45 | 21,386.0428 | 83,900,000 | 0.64% | 0.00% |
| Feb. 11, 2024 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | M | Restricted Stock Unit | 472 | $0.00 | 15,296.0000 | 83,900,000 | 2.99% | 0.00% |
| Feb. 11, 2024 | BERBERIAN LANCE | EVP, CIO & CTO | M | Common Stock | 324 | $0.00 | 23,703.0000 | 83,900,000 | 1.39% | 0.00% |
| Feb. 12, 2024 | BERBERIAN LANCE | EVP, CIO & CTO | F | Common Stock | 87 | $227.45 | 23,616.0000 | 83,900,000 | 0.37% | 0.00% |
| Feb. 8, 2024 | van der Vaart Sandra D | EVP, Chief Legal Officer | S | Common Stock | 259 | $222.06 | 7,636.9790 | 83,900,000 | 3.28% | 0.00% |
| Feb. 7, 2024 | DiVincenzo Jonathan P. | EVP, Pres, Central Labs & Intl | M | Common Stock | 138 | $0.00 | 3,799.5491 | 83,900,000 | 3.77% | 0.00% |
| Feb. 7, 2024 | DiVincenzo Jonathan P. | EVP, Pres, Central Labs & Intl | F | Common Stock | 41 | $223.71 | 3,758.5491 | 83,900,000 | 1.08% | 0.00% |
| Feb. 6, 2024 | NEUPERT PETER M | Director | A | Restricted Stock Unit | 944 | $0.00 | 1,891.0000 | 83,900,000 | 99.68% | 0.00% |
| Feb. 6, 2024 | GRAHAM ANITA Z | EVP, CHRO | A | Restricted Stock Unit | 980 | $0.00 | 2,085.0000 | 83,900,000 | 88.69% | 0.00% |
| Feb. 7, 2024 | GRAHAM ANITA Z | EVP, CHRO | F | Common Stock | 107 | $223.71 | 292.0000 | 83,900,000 | 26.82% | 0.00% |
| Feb. 7, 2024 | GRAHAM ANITA Z | EVP, CHRO | M | Common Stock | 369 | $0.00 | 399.0000 | 83,900,000 | 1230.00% | 0.00% |
| Feb. 7, 2024 | Bailey Megan D. | EVP, Chief Strategy Officer | M | Restricted Stock Unit | 67 | $0.00 | 5,612.0000 | 83,900,000 | 1.18% | 0.00% |
| Feb. 7, 2024 | Bailey Megan D. | EVP, Chief Strategy Officer | M | Restricted Stock Unit | 224 | $0.00 | 5,679.0000 | 83,900,000 | 3.79% | 0.00% |
| Feb. 6, 2024 | Bailey Megan D. | EVP, Chief Strategy Officer | A | Non-qualified Stock Options | 1700 | $0.00 | 1,700.0000 | 83,900,000 | 9999.99% | 0.00% |
| Feb. 6, 2024 | Bailey Megan D. | EVP, Chief Strategy Officer | A | Restricted Stock Unit | 540 | $0.00 | 5,903.0000 | 83,900,000 | 10.07% | 0.00% |
| Feb. 7, 2024 | Bailey Megan D. | EVP, Chief Strategy Officer | F | Common Stock | 26 | $223.71 | 300.0000 | 83,900,000 | 7.98% | 0.00% |
| Feb. 7, 2024 | Bailey Megan D. | EVP, Chief Strategy Officer | M | Common Stock | 67 | $0.00 | 326.0000 | 83,900,000 | 25.87% | 0.00% |
| Feb. 7, 2024 | Bailey Megan D. | EVP, Chief Strategy Officer | F | Common Stock | 87 | $223.71 | 259.0000 | 83,900,000 | 25.14% | 0.00% |
| Feb. 7, 2024 | Bailey Megan D. | EVP, Chief Strategy Officer | M | Common Stock | 224 | $0.00 | 346.0000 | 83,900,000 | 183.61% | 0.00% |
| Feb. 7, 2024 | BERBERIAN LANCE | EVP, CIO & CTO | M | Restricted Stock Unit | 353 | $0.00 | 10,121.0000 | 83,900,000 | 3.37% | 0.00% |
| Feb. 6, 2024 | BERBERIAN LANCE | EVP, CIO & CTO | A | Non-qualified Stock Options | 3300 | $0.00 | 3,300.0000 | 83,900,000 | 9999.99% | 0.00% |
| Feb. 6, 2024 | BERBERIAN LANCE | EVP, CIO & CTO | A | Restricted Stock Unit | 1070 | $0.00 | 10,474.0000 | 83,900,000 | 11.38% | 0.00% |
| Feb. 7, 2024 | BERBERIAN LANCE | EVP, CIO & CTO | F | Common Stock | 94 | $223.71 | 23,379.0000 | 83,900,000 | 0.40% | 0.00% |
| Feb. 7, 2024 | BERBERIAN LANCE | EVP, CIO & CTO | M | Common Stock | 353 | $0.00 | 23,473.0000 | 83,900,000 | 1.53% | 0.00% |
| Feb. 7, 2024 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | M | Restricted Stock Unit | 112 | $0.00 | 15,768.0000 | 83,900,000 | 0.71% | 0.00% |
| Feb. 7, 2024 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | M | Restricted Stock Unit | 517 | $0.00 | 15,880.0000 | 83,900,000 | 3.15% | 0.00% |
| Feb. 6, 2024 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | A | Non-qualified Stock Options | 6200 | $0.00 | 6,200.0000 | 83,900,000 | 9999.99% | 0.01% |
| Feb. 6, 2024 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | A | Restricted Stock Unit | 2010 | $0.00 | 16,397.0000 | 83,900,000 | 13.97% | 0.00% |
| Feb. 7, 2024 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | F | Common Stock | 33 | $223.71 | 21,051.0428 | 83,900,000 | 0.16% | 0.00% |
| Feb. 7, 2024 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | M | Common Stock | 112 | $0.00 | 21,084.0428 | 83,900,000 | 0.53% | 0.00% |
| Feb. 7, 2024 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | F | Common Stock | 171 | $223.71 | 20,972.0428 | 83,900,000 | 0.81% | 0.00% |
| Feb. 7, 2024 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | M | Common Stock | 517 | $0.00 | 21,143.0428 | 83,900,000 | 2.51% | 0.00% |
| Feb. 7, 2024 | DiVincenzo Jonathan P. | EVP, Pres, Central Labs & Intl | M | Restricted Stock Unit | 138 | $0.00 | 5,178.0000 | 83,900,000 | 2.60% | 0.00% |
| Feb. 7, 2024 | DiVincenzo Jonathan P. | EVP, Pres, Central Labs & Intl | M | Restricted Stock Unit | 224 | $0.00 | 5,316.0000 | 83,900,000 | 4.04% | 0.00% |
| Feb. 6, 2024 | DiVincenzo Jonathan P. | EVP, Pres, Central Labs & Intl | A | Non-qualified Stock Options | 3000 | $0.00 | 3,000.0000 | 83,900,000 | 9999.99% | 0.00% |
| Feb. 7, 2024 | Schechter Adam H | President & CEO | M | Common Stock | 3250 | $0.00 | 52,410.0000 | 83,900,000 | 6.61% | 0.00% |
| Feb. 7, 2024 | Schechter Adam H | President & CEO | F | Common Stock | 1149 | $223.71 | 51,261.0000 | 83,900,000 | 2.19% | 0.00% |
| Feb. 6, 2024 | Schechter Adam H | President & CEO | A | Restricted Stock Unit | 13380 | $0.00 | 101,491.0000 | 83,900,000 | 15.19% | 0.02% |
| Feb. 6, 2024 | Schechter Adam H | President & CEO | A | Non-qualified Stock Options | 41400 | $0.00 | 41,400.0000 | 83,900,000 | 9999.99% | 0.05% |
| Feb. 7, 2024 | Schechter Adam H | President & CEO | M | Restricted Stock Unit | 3250 | $0.00 | 98,241.0000 | 83,900,000 | 3.20% | 0.00% |
| Feb. 7, 2024 | EISENBERG GLENN A | Chief Financial Officer, EVP | M | Common Stock | 885 | $0.00 | 43,689.0000 | 83,900,000 | 2.07% | 0.00% |
| Feb. 7, 2024 | EISENBERG GLENN A | Chief Financial Officer, EVP | F | Common Stock | 236 | $223.71 | 43,453.0000 | 83,900,000 | 0.54% | 0.00% |
| Feb. 6, 2024 | EISENBERG GLENN A | Chief Financial Officer, EVP | A | Restricted Stock Unit | 2900 | $0.00 | 37,431.0000 | 83,900,000 | 8.40% | 0.00% |
| Feb. 6, 2024 | EISENBERG GLENN A | Chief Financial Officer, EVP | A | Non-qualified Stock Options | 9000 | $0.00 | 9,000.0000 | 83,900,000 | 9999.99% | 0.01% |
| Feb. 7, 2024 | EISENBERG GLENN A | Chief Financial Officer, EVP | M | Restricted Stock Unit | 885 | $0.00 | 36,546.0000 | 83,900,000 | 2.36% | 0.00% |
| Feb. 7, 2024 | DiVincenzo Jonathan P. | EVP, Pres, Central Labs & Intl | M | Common Stock | 224 | $0.00 | 3,739.5491 | 83,900,000 | 6.37% | 0.00% |
| Feb. 7, 2024 | DiVincenzo Jonathan P. | EVP, Pres, Central Labs & Intl | F | Common Stock | 78 | $223.71 | 3,661.5491 | 83,900,000 | 2.09% | 0.00% |
| Feb. 6, 2024 | Williams R Sanders | Director | A | Restricted Stock Unit | 236 | $0.00 | 1,183.0000 | 83,900,000 | 24.92% | 0.00% |
| Feb. 7, 2024 | Williams R Sanders | Director | M | Common Stock | 947 | $0.00 | 8,120.0000 | 83,900,000 | 13.20% | 0.00% |
| Feb. 6, 2024 | Rothman Paul | Director | A | Restricted Stock Unit | 944 | $0.00 | 1,661.0000 | 83,900,000 | 131.66% | 0.00% |
| Feb. 7, 2024 | Wilkinson Peter J | SVP, Chief Accounting Officer | M | Restricted Stock Unit | 134 | $0.00 | 3,993.0000 | 83,900,000 | 3.25% | 0.00% |
| Feb. 6, 2024 | Wilkinson Peter J | SVP, Chief Accounting Officer | A | Non-qualified Stock Options | 1200 | $0.00 | 1,200.0000 | 83,900,000 | 9999.99% | 0.00% |
| Feb. 6, 2024 | Wilkinson Peter J | SVP, Chief Accounting Officer | A | Restricted Stock Unit | 400 | $0.00 | 4,127.0000 | 83,900,000 | 10.73% | 0.00% |
| Feb. 7, 2024 | Wilkinson Peter J | SVP, Chief Accounting Officer | F | Common Stock | 46 | $223.71 | 2,261.2194 | 83,900,000 | 1.99% | 0.00% |
| Feb. 7, 2024 | Wilkinson Peter J | SVP, Chief Accounting Officer | M | Common Stock | 134 | $0.00 | 2,307.2194 | 83,900,000 | 6.17% | 0.00% |
| Feb. 7, 2024 | van der Vaart Sandra D | EVP, Chief Legal Officer | M | Restricted Stock Unit | 353 | $0.00 | 8,672.0000 | 83,900,000 | 3.91% | 0.00% |
| Feb. 6, 2024 | van der Vaart Sandra D | EVP, Chief Legal Officer | A | Non-qualified Stock Options | 3600 | $0.00 | 3,600.0000 | 83,900,000 | 9999.99% | 0.00% |
| Feb. 6, 2024 | van der Vaart Sandra D | EVP, Chief Legal Officer | A | Restricted Stock Unit | 1160 | $0.00 | 9,025.0000 | 83,900,000 | 14.75% | 0.00% |
| Feb. 7, 2024 | van der Vaart Sandra D | EVP, Chief Legal Officer | F | Common Stock | 94 | $223.71 | 7,895.9790 | 83,900,000 | 1.18% | 0.00% |
| Feb. 7, 2024 | van der Vaart Sandra D | EVP, Chief Legal Officer | M | Common Stock | 353 | $0.00 | 7,989.9790 | 83,900,000 | 4.62% | 0.00% |
| Feb. 7, 2024 | Summy Amy B. | EVP, Chief Marketing Officer | M | Restricted Stock Unit | 224 | $0.00 | 7,296.0000 | 83,900,000 | 2.98% | 0.00% |
| Feb. 6, 2024 | Summy Amy B. | EVP, Chief Marketing Officer | A | Non-qualified Stock Options | 2100 | $0.00 | 2,100.0000 | 83,900,000 | 9999.99% | 0.00% |
| Feb. 6, 2024 | Summy Amy B. | EVP, Chief Marketing Officer | A | Restricted Stock Unit | 670 | $0.00 | 7,520.0000 | 83,900,000 | 9.78% | 0.00% |
| Feb. 7, 2024 | Summy Amy B. | EVP, Chief Marketing Officer | F | Common Stock | 73 | $223.71 | 3,951.0000 | 83,900,000 | 1.81% | 0.00% |
| Feb. 7, 2024 | Summy Amy B. | EVP, Chief Marketing Officer | M | Common Stock | 224 | $0.00 | 4,024.0000 | 83,900,000 | 5.89% | 0.00% |
| Feb. 7, 2024 | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Restricted Stock Unit | 163 | $0.00 | 16,093.0000 | 83,900,000 | 1.00% | 0.00% |
| Feb. 7, 2024 | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Restricted Stock Unit | 517 | $0.00 | 16,256.0000 | 83,900,000 | 3.08% | 0.00% |
| Feb. 6, 2024 | Schroeder Mark S | EVP, Pres Diagnostics & COO | A | Non-qualified Stock Options | 6900 | $0.00 | 6,900.0000 | 83,900,000 | 9999.99% | 0.01% |
| Feb. 6, 2024 | Schroeder Mark S | EVP, Pres Diagnostics & COO | A | Restricted Stock Unit | 2230 | $0.00 | 16,773.0000 | 83,900,000 | 15.33% | 0.00% |
| Feb. 7, 2024 | Schroeder Mark S | EVP, Pres Diagnostics & COO | F | Common Stock | 44 | $223.71 | 7,619.1426 | 83,900,000 | 0.57% | 0.00% |
| Feb. 7, 2024 | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Common Stock | 163 | $0.00 | 7,663.1426 | 83,900,000 | 2.17% | 0.00% |
| Feb. 7, 2024 | Schroeder Mark S | EVP, Pres Diagnostics & COO | F | Common Stock | 138 | $223.71 | 7,500.1426 | 83,900,000 | 1.81% | 0.00% |
| Feb. 7, 2024 | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Common Stock | 517 | $0.00 | 7,638.1426 | 83,900,000 | 7.26% | 0.00% |
| Feb. 7, 2024 | GRAHAM ANITA Z | EVP, CHRO | M | Restricted Stock Unit | 369 | $0.00 | 1,716.0000 | 83,900,000 | 17.70% | 0.00% |
| Feb. 6, 2024 | GRAHAM ANITA Z | EVP, CHRO | A | Non-qualified Stock Options | 3000 | $0.00 | 3,000.0000 | 83,900,000 | 9999.99% | 0.00% |
| Feb. 7, 2024 | ANDERSON KERRII B | Director | M | Restricted Stock Unit | 947 | $0.00 | 944.0000 | 83,900,000 | 50.08% | 0.00% |
| Feb. 6, 2024 | ANDERSON KERRII B | Director | A | Restricted Stock Unit | 944 | $0.00 | 1,891.0000 | 83,900,000 | 99.68% | 0.00% |
| Feb. 7, 2024 | ANDERSON KERRII B | Director | M | Common Stock | 947 | $0.00 | 16,510.0000 | 83,900,000 | 6.08% | 0.00% |
| Feb. 7, 2024 | BELINGARD JEAN-LUC | Director | M | Restricted Stock Unit | 947 | $0.00 | 236.0000 | 83,900,000 | 80.05% | 0.00% |
| Feb. 6, 2024 | BELINGARD JEAN-LUC | Director | A | Restricted Stock Unit | 236 | $0.00 | 1,183.0000 | 83,900,000 | 24.92% | 0.00% |
| Feb. 7, 2024 | BELINGARD JEAN-LUC | Director | F | Common Stock | 95 | $223.71 | 17,781.0000 | 83,900,000 | 0.53% | 0.00% |
| Feb. 7, 2024 | BELINGARD JEAN-LUC | Director | M | Common Stock | 947 | $0.00 | 17,876.0000 | 83,900,000 | 5.59% | 0.00% |
| Feb. 7, 2024 | Davis Jeffrey A. | Director | M | Restricted Stock Unit | 947 | $0.00 | 944.0000 | 83,900,000 | 50.08% | 0.00% |
| Feb. 6, 2024 | Davis Jeffrey A. | Director | A | Restricted Stock Unit | 944 | $0.00 | 1,891.0000 | 83,900,000 | 99.68% | 0.00% |
| Feb. 7, 2024 | Davis Jeffrey A. | Director | M | Common Stock | 947 | $0.00 | 3,619.0000 | 83,900,000 | 35.44% | 0.00% |
| Feb. 7, 2024 | Gilliland Dwight Gary | Director | M | Restricted Stock Unit | 947 | $0.00 | 944.0000 | 83,900,000 | 50.08% | 0.00% |
| Feb. 6, 2024 | Gilliland Dwight Gary | Director | A | Restricted Stock Unit | 944 | $0.00 | 1,891.0000 | 83,900,000 | 99.68% | 0.00% |
| Feb. 7, 2024 | Gilliland Dwight Gary | Director | M | Common Stock | 947 | $0.00 | 8,712.0000 | 83,900,000 | 12.20% | 0.00% |
| Feb. 7, 2024 | Kliphouse Kirsten Marie | Director | M | Restricted Stock Unit | 947 | $0.00 | 944.0000 | 83,900,000 | 50.08% | 0.00% |
| Feb. 6, 2024 | Kliphouse Kirsten Marie | Director | A | Restricted Stock Unit | 944 | $0.00 | 1,891.0000 | 83,900,000 | 99.68% | 0.00% |
| Feb. 7, 2024 | Kliphouse Kirsten Marie | Director | M | Common Stock | 947 | $0.00 | 1,319.0000 | 83,900,000 | 254.57% | 0.00% |
| Feb. 7, 2024 | Kong Garheng | Director | M | Restricted Stock Unit | 947 | $0.00 | 944.0000 | 83,900,000 | 50.08% | 0.00% |
| Feb. 6, 2024 | Kong Garheng | Director | A | Restricted Stock Unit | 944 | $0.00 | 1,891.0000 | 83,900,000 | 99.68% | 0.00% |
| Feb. 7, 2024 | Kong Garheng | Director | M | Common Stock | 947 | $0.00 | 11,898.0000 | 83,900,000 | 8.65% | 0.00% |
| Feb. 7, 2024 | NEUPERT PETER M | Director | M | Restricted Stock Unit | 947 | $0.00 | 944.0000 | 83,900,000 | 50.08% | 0.00% |
| Feb. 6, 2024 | DiVincenzo Jonathan P. | EVP, Pres, Central Labs & Intl | A | Restricted Stock Unit | 980 | $0.00 | 5,540.0000 | 83,900,000 | 21.49% | 0.00% |
| Feb. 7, 2024 | NEUPERT PETER M | Director | M | Common Stock | 947 | $0.00 | 11,943.0000 | 83,900,000 | 8.61% | 0.00% |
| Feb. 7, 2024 | Parham Richelle P | Director | M | Restricted Stock Unit | 947 | $0.00 | 944.0000 | 83,900,000 | 50.08% | 0.00% |
| Feb. 6, 2024 | Parham Richelle P | Director | A | Restricted Stock Unit | 944 | $0.00 | 1,891.0000 | 83,900,000 | 99.68% | 0.00% |
| Feb. 7, 2024 | Parham Richelle P | Director | M | Common Stock | 947 | $0.00 | 8,534.0000 | 83,900,000 | 12.48% | 0.00% |
| Feb. 7, 2024 | Wengel Kathryn E | Director | M | Restricted Stock Unit | 947 | $0.00 | 944.0000 | 83,900,000 | 50.08% | 0.00% |
| Feb. 6, 2024 | Wengel Kathryn E | Director | A | Restricted Stock Unit | 944 | $0.00 | 1,891.0000 | 83,900,000 | 99.68% | 0.00% |
| Feb. 7, 2024 | Wengel Kathryn E | Director | M | Common Stock | 947 | $0.00 | 2,292.0000 | 83,900,000 | 70.41% | 0.00% |
| Feb. 7, 2024 | Williams R Sanders | Director | M | Restricted Stock Unit | 947 | $0.00 | 236.0000 | 83,900,000 | 80.05% | 0.00% |
| Feb. 2, 2024 | Wilkinson Peter J | SVP, Chief Accounting Officer | M | Common Stock | 131 | $0.00 | 2,218.2194 | 83,900,000 | 6.28% | 0.00% |
| Feb. 2, 2024 | van der Vaart Sandra D | EVP, Chief Legal Officer | F | Common Stock | 71 | $221.54 | 7,829.9790 | 83,900,000 | 0.90% | 0.00% |
| Feb. 5, 2024 | van der Vaart Sandra D | EVP, Chief Legal Officer | S | Common Stock | 193 | $220.57 | 7,636.9790 | 83,900,000 | 2.46% | 0.00% |
| Feb. 2, 2024 | van der Vaart Sandra D | EVP, Chief Legal Officer | M | Restricted Stock Unit | 264 | $0.00 | 7,865.0000 | 83,900,000 | 3.25% | 0.00% |
| Feb. 2, 2024 | Wilkinson Peter J | SVP, Chief Accounting Officer | F | Common Stock | 45 | $221.54 | 2,173.2194 | 83,900,000 | 2.03% | 0.00% |
| Feb. 2, 2024 | Wilkinson Peter J | SVP, Chief Accounting Officer | M | Restricted Stock Unit | 131 | $0.00 | 3,727.0000 | 83,900,000 | 3.40% | 0.00% |
| Feb. 2, 2024 | Summy Amy B. | EVP, Chief Marketing Officer | M | Common Stock | 246 | $0.00 | 3,880.0000 | 83,900,000 | 6.77% | 0.00% |
| Feb. 2, 2024 | Summy Amy B. | EVP, Chief Marketing Officer | F | Common Stock | 80 | $221.54 | 3,800.0000 | 83,900,000 | 2.06% | 0.00% |
| Feb. 2, 2024 | Summy Amy B. | EVP, Chief Marketing Officer | M | Restricted Stock Unit | 246 | $0.00 | 6,850.0000 | 83,900,000 | 3.47% | 0.00% |
| Feb. 2, 2024 | BERBERIAN LANCE | EVP, CIO & CTO | M | Common Stock | 331 | $0.00 | 23,209.0000 | 83,900,000 | 1.45% | 0.00% |
| Feb. 2, 2024 | BERBERIAN LANCE | EVP, CIO & CTO | F | Common Stock | 89 | $221.54 | 23,120.0000 | 83,900,000 | 0.38% | 0.00% |
| Feb. 2, 2024 | BERBERIAN LANCE | EVP, CIO & CTO | M | Restricted Stock Unit | 331 | $0.00 | 9,404.0000 | 83,900,000 | 3.40% | 0.00% |
| Feb. 2, 2024 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | M | Common Stock | 495 | $0.00 | 20,792.0428 | 83,900,000 | 2.44% | 0.00% |
| Feb. 2, 2024 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | F | Common Stock | 166 | $221.54 | 20,626.0428 | 83,900,000 | 0.80% | 0.00% |
| Feb. 2, 2024 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | M | Restricted Stock Unit | 495 | $0.00 | 14,387.0000 | 83,900,000 | 3.33% | 0.00% |
| Feb. 2, 2024 | Schechter Adam H | President & CEO | M | Common Stock | 3094 | $0.00 | 49,982.0000 | 83,900,000 | 6.60% | 0.00% |
| Feb. 2, 2024 | Schechter Adam H | President & CEO | F | Common Stock | 822 | $221.54 | 49,160.0000 | 83,900,000 | 1.64% | 0.00% |
| Feb. 2, 2024 | Schechter Adam H | President & CEO | M | Restricted Stock Unit | 3094 | $0.00 | 88,111.0000 | 83,900,000 | 3.39% | 0.00% |
| Feb. 2, 2024 | DiVincenzo Jonathan P. | EVP, Pres, Central Labs & Intl | M | Common Stock | 246 | $0.00 | 3,600.5491 | 83,900,000 | 7.33% | 0.00% |
| Feb. 2, 2024 | DiVincenzo Jonathan P. | EVP, Pres, Central Labs & Intl | F | Common Stock | 85 | $221.54 | 3,515.5491 | 83,900,000 | 2.36% | 0.00% |
| Feb. 2, 2024 | DiVincenzo Jonathan P. | EVP, Pres, Central Labs & Intl | M | Restricted Stock Unit | 246 | $0.00 | 4,560.0000 | 83,900,000 | 5.12% | 0.00% |
| Feb. 2, 2024 | EISENBERG GLENN A | Chief Financial Officer, EVP | M | Common Stock | 856 | $0.00 | 43,032.0000 | 83,900,000 | 2.03% | 0.00% |
| Feb. 2, 2024 | EISENBERG GLENN A | Chief Financial Officer, EVP | F | Common Stock | 228 | $221.54 | 42,804.0000 | 83,900,000 | 0.53% | 0.00% |
| Feb. 2, 2024 | EISENBERG GLENN A | Chief Financial Officer, EVP | M | Restricted Stock Unit | 856 | $0.00 | 34,531.0000 | 83,900,000 | 2.42% | 0.00% |
| Feb. 2, 2024 | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Common Stock | 495 | $0.00 | 7,253.1426 | 83,900,000 | 7.32% | 0.00% |
| Feb. 2, 2024 | Schroeder Mark S | EVP, Pres Diagnostics & COO | F | Common Stock | 132 | $221.54 | 7,121.1426 | 83,900,000 | 1.82% | 0.00% |
| Feb. 2, 2024 | Schroeder Mark S | EVP, Pres Diagnostics & COO | M | Restricted Stock Unit | 495 | $0.00 | 14,543.0000 | 83,900,000 | 3.29% | 0.00% |
| Feb. 2, 2024 | van der Vaart Sandra D | EVP, Chief Legal Officer | M | Common Stock | 264 | $0.00 | 7,900.9790 | 83,900,000 | 3.46% | 0.00% |